Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Vascular Surgery

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 815 articles:
HTML format



Single Articles


    May 2024
  1. YE C, Ma X, Shi B, Yan R, et al
    Obesity is associated with acute kidney injury in ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention: A national representative cohort study.
    Catheter Cardiovasc Interv. 2024;103:897-908.
    PubMed     Abstract available


  2. GIACOBBE F, Valente E, Morena A, Nebiolo M, et al
    Safety and efficacy of drug-eluting stents for patients at high risk of bleedings: A network meta-analysis.
    Catheter Cardiovasc Interv. 2024;103:843-855.
    PubMed     Abstract available


  3. SATO T, Matsumura M, Yamamoto K, Shlofmitz E, et al
    Prevalence and anatomical factors associated with stent under-expansion in non-severely calcified lesions.
    Catheter Cardiovasc Interv. 2024;103:833-842.
    PubMed     Abstract available


  4. KAWAI K, Madra A, Kawakami R, Sato Y, et al
    Effect of EDTA with porous balloon on calcified lesion: An atherosclerotic cadaver study.
    Catheter Cardiovasc Interv. 2024;103:972-981.
    PubMed     Abstract available


  5. CASE BC, Bazarbashi N, Johnson A, Rogers T, et al
    A novel approach to saline/contrast delivery in excimer laser coronary atherectomy (ELCA) to enhance efficacy: MAXCon ELCA technique.
    Catheter Cardiovasc Interv. 2024;103:917-923.
    PubMed     Abstract available


  6. GOYAL A, Fatima L, Mushtaq F, Tariq MD, et al
    Comparison between the outcomes of transfemoral access and transfemoral access with adjunct upper extremity access in patients undergoing endovascular aortic repair: A pilot systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2024;103:982-994.
    PubMed     Abstract available


  7. ZHANG RS, Alviar CL, Yuriditsky E, Alam U, et al
    Percutaneous mechanical thrombectomy in acute pulmonary embolism: Outcomes from a safety-net hospital.
    Catheter Cardiovasc Interv. 2024;103:1042-1049.
    PubMed     Abstract available


  8. DAS TS, Shammas NW, Yoho JA, Martinez-Clark P, et al
    Solid state, pulsed-wave 355 nm UV laser atherectomy debulking in the treatment of infrainguinal peripheral arterial disease: The Pathfinder Registry.
    Catheter Cardiovasc Interv. 2024;103:949-962.
    PubMed     Abstract available


    April 2024
  9. REMPAKOS A, Alexandrou M, Mutlu D, Choi JW, et al
    Validation of the BCIS CHIP Score in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Apr 17. doi: 10.1002/ccd.31045.
    PubMed     Abstract available


  10. OZTAS DM, Ozdemir E, Bauernschmitt R, Ugurlucan M, et al
    Transcatheter aortic valve implantation for pure aortic insufficiency in a patient following David-type aortic valve-sparing root replacement after aortic dissection-A successful off-label procedure.
    Catheter Cardiovasc Interv. 2024 Apr 5. doi: 10.1002/ccd.31033.
    PubMed     Abstract available


  11. AL-OGAILI A, Alexandrou M, Rempakos A, Mutlu D, et al
    Retrograde chronic total occlusion percutaneous coronary intervention via ipsilateral collaterals.
    Catheter Cardiovasc Interv. 2024 Apr 2. doi: 10.1002/ccd.31019.
    PubMed     Abstract available


  12. BHOGAL S, Garg M, Meda NS, Merdler I, et al
    Reasons for repeat urgent cardiac procedures within the same day.
    Catheter Cardiovasc Interv. 2024;103:691-694.
    PubMed     Abstract available


  13. LEI J, Pu H, Zhang L, Zeng C, et al
    Drug-coated balloon therapy for in-stent restenosis in patients with iliofemoral deep vein thrombosis: A single-arm observational study.
    Catheter Cardiovasc Interv. 2024;103:752-757.
    PubMed     Abstract available


    March 2024
  14. GIORDANO A, Biondi-Zoccai G
    Which is the best approach for percutaneous coronary intervention of chronic total occlusions? The one you feel most confident with!
    Catheter Cardiovasc Interv. 2024 Mar 20. doi: 10.1002/ccd.31011.
    PubMed    


  15. SETO AH, Yau P
    Does ejection fraction matter in choosing between percutaneous coronary intervention and coronary artery bypass surgery?
    Catheter Cardiovasc Interv. 2024 Mar 17. doi: 10.1002/ccd.31014.
    PubMed    


  16. POOMMIPANIT P, Tashtish N
    The utility of guide catheter extensions (GCE) in coronary interventions and specifically chronic total occlusion (CTO) interventions.
    Catheter Cardiovasc Interv. 2024 Mar 15. doi: 10.1002/ccd.31012.
    PubMed    


  17. TOLEDANO BRF, Garganera KB, Prado JPA, Sabas ML, et al
    Routine preprocedural ultrasound in palpation versus ultrasound guided radial access for cardiac catheterization.
    Catheter Cardiovasc Interv. 2024 Mar 12. doi: 10.1002/ccd.31005.
    PubMed     Abstract available


  18. VELAGALETI RS, Harrell C, Michalski J, Lefevre T, et al
    Impact of preprocedural left ventricular systolic function on the safety and durability of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Mar 5. doi: 10.1002/ccd.30995.
    PubMed     Abstract available


  19. FILHO EM, Araujo GN, Machado GP, Padilla L, et al
    Guide catheter extension use are associated with higher procedural success in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2024 Mar 3. doi: 10.1002/ccd.30987.
    PubMed     Abstract available


  20. DENBY K, Zaczkiewicz M, Banthiya S, Mashayekhi K, et al
    Understanding large vessel perforation requiring treatment with covered stent implantation: A case series.
    Catheter Cardiovasc Interv. 2024;103:570-579.
    PubMed     Abstract available


  21. UZUN F, Guner A, Demirci G, Ciloglu K, et al
    Comparison of long-term outcomes of double kissing crush versus T and minimal protrusion techniques in complex bifurcation lesions: The EVOLUTE-CRUSH II registry.
    Catheter Cardiovasc Interv. 2024;103:511-522.
    PubMed     Abstract available


  22. SCHELLER B
    Drug-coated balloons for complex coronary de novo lesions.
    Catheter Cardiovasc Interv. 2024;103:688-689.
    PubMed    


  23. ALEKSANDRIC S, Beleslin B
    Editorial comment: SYNTAX score II 2020 as a tool for decision making on revascularization strategy in high-risk patients with complex coronary artery disease.
    Catheter Cardiovasc Interv. 2024;103:680-681.
    PubMed    


  24. POLETTI E, Zivelonghi C, Dens J, Bennett J, et al
    Performance of the minimalistic hybrid approach algorithm versus other conventional algorithms in the percutaneous treatment of chronic total occlusions.
    Catheter Cardiovasc Interv. 2024;103:548-559.
    PubMed     Abstract available


    February 2024
  25. PENG S, Rempakos A, Mastrodemos OC, Rangan BV, et al
    Use of the Indigo CAT RX aspiration system during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.30994.
    PubMed     Abstract available


  26. AL-TERKI H, Lauder L, Mugge A, Gotzinger F, et al
    Ultrasound-assisted endovascular thrombolysis versus large-bore thrombectomy in acute intermediate-high risk pulmonary embolism: The propensity-matched EKNARI cohort study.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.30998.
    PubMed     Abstract available


  27. ANDREKA J, Sasi V, Toth GG, Ruzsa Z, et al
    Stent graft implantation from distal radial access-A novel way to treat femoral access site complication during transcatheter aortic valve replacement: A case report.
    Catheter Cardiovasc Interv. 2024 Feb 28. doi: 10.1002/ccd.31001.
    PubMed     Abstract available


  28. BOUSSOFARA A, Godin M, Canville A, Baala B, et al
    Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: A single-centre observational study.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30969.
    PubMed     Abstract available


  29. CORCIONE N, Biondi-Zoccai G
    ABC as in Arteriopathy, Bleeding, and Coronary disease: Disentangling the prognostic conundrum of patients undergoing percutaneous coronary intervention with concomitant peripheral artery disease.
    Catheter Cardiovasc Interv. 2024 Feb 22. doi: 10.1002/ccd.30982.
    PubMed    


  30. KELLEY BP, Glasco S, Sang CJ 3rd, Yoo B, et al
    To flip or not: Case series of coronary angioplasty in patients with right-sided heart.
    Catheter Cardiovasc Interv. 2024 Feb 12. doi: 10.1002/ccd.30973.
    PubMed     Abstract available


  31. SPIRITO A, Cohen R, Sartori S, Vogel B, et al
    Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 5. doi: 10.1002/ccd.30960.
    PubMed     Abstract available


  32. JEYAPRAKASH P, Mikhail P, Ford TJ, Pathan F, et al
    Index of Microcirculatory Resistance to predict microvascular obstruction in STEMI: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2024;103:249-259.
    PubMed     Abstract available


  33. JOLLEY MA, Sulentic A, Amin S, Gupta M, et al
    Introduction of transcatheter edge-to-edge repair in patients with congenital heart disease at a children's hospital.
    Catheter Cardiovasc Interv. 2024;103:326-334.
    PubMed     Abstract available


  34. SUZUKA Y, Hirano K, Tokuda T, Diaz JP, et al
    JETWING technique: Combination therapy of JETSTREAM(?) and aggressive wire recanalization in calcified atheroma and dilatation technique for eccentric heavy calcified plaques using WINGMAN for insertion of protection wire.
    Catheter Cardiovasc Interv. 2024;103:335-339.
    PubMed     Abstract available


  35. MOSCARDELLI S, Condos G, Lombardi WL, Azzalini L, et al
    Intracoronary snaring of the retrograde guidewire: A novel method to solve compartment mismatch in complex retrograde CTO PCI.
    Catheter Cardiovasc Interv. 2024;103:435-442.
    PubMed     Abstract available


  36. FUNATSU A, Sato T, Koike J, Mizobuchi M, et al
    Comprehensive clinical outcomes of drug-coated balloon treatment for coronary artery disease. Insights from a single-center experience.
    Catheter Cardiovasc Interv. 2024;103:404-416.
    PubMed     Abstract available


  37. LI M, Liu X, Jiang M, Lei Y, et al
    External validation of the SYNTAX score II 2020 in patients with chronic renal insufficiency.
    Catheter Cardiovasc Interv. 2024;103:391-403.
    PubMed     Abstract available


    January 2024
  38. SINGH K, Niranjan S, Hibbert B, Taramasso M, et al
    A stepwise approach to coronary artery stenting in acute type A aortic dissection.
    Catheter Cardiovasc Interv. 2024 Jan 31. doi: 10.1002/ccd.30964.
    PubMed     Abstract available


  39. VOLET C, Puricel S, Cook ST, di Cicco P, et al
    Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL-LM.
    Catheter Cardiovasc Interv. 2024 Jan 31. doi: 10.1002/ccd.30961.
    PubMed     Abstract available


  40. CHICHAREON P, Chamnarnphol N, Chandavimol M, Suwannasom P, et al
    Updated CRUSADE score to predict in-hospital bleeding: External validation in the Thai percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2024 Jan 14. doi: 10.1002/ccd.30940.
    PubMed     Abstract available


  41. JONES D, Spirito A, Sartori S, Vogel B, et al
    Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Jan 3. doi: 10.1002/ccd.30939.
    PubMed     Abstract available


  42. BIANCHINI F, Lombardi M, Ricchiuto A, Paraggio L, et al
    Combined ultrasound and angiographic guidance to facilitate transradial access procedures.
    Catheter Cardiovasc Interv. 2024 Jan 3. doi: 10.1002/ccd.30947.
    PubMed     Abstract available


  43. FERNANDEZ CM, Shroff AR, Vidovich MI
    Interventional cardiologist perceptions about PCI without surgical backup-Results of an international survey.
    Catheter Cardiovasc Interv. 2024;103:20-29.
    PubMed     Abstract available


  44. KAWAMURA A, Egami Y, Okamoto N, Kawanami S, et al
    Difference between antegrade and retrograde orbital atherectomy system debulking using an artificial pulsatile heart model.
    Catheter Cardiovasc Interv. 2024;103:42-50.
    PubMed     Abstract available


  45. SHEKILADZE N, Sandesara PB, Tai Z, Maisuradze N, et al
    Technical aspects of entrapped coronary guidewire retrieval using rotational atherectomy device: A case series.
    Catheter Cardiovasc Interv. 2024;103:89-96.
    PubMed     Abstract available


  46. GUPTA A, Shrivastava A, Chhikara S, Mamas MA, et al
    Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study).
    Catheter Cardiovasc Interv. 2024;103:51-60.
    PubMed     Abstract available


  47. EFFOE VS, Mewissen MW, Bajwa TK, Khitha J, et al
    Effects of atherectomy on major adverse limb events for femoropopliteal interventions: Vascular Quality Initiative registry.
    Catheter Cardiovasc Interv. 2024;103:106-114.
    PubMed     Abstract available


  48. HARAGUCHI T, Kuramitsu S, Tsujimoto M, Kashima Y, et al
    Outcomes of non-flow-limiting spiral dissection after drug-coated balloon angioplasty for de novo femoropopliteal lesions.
    Catheter Cardiovasc Interv. 2024;103:97-105.
    PubMed     Abstract available


  49. UNGUREANU C, Cocoi M, Colletti G, Avran A, et al
    Successful treatment by recross IVUS-guided reentry in coronary total occlusion: STRIVE-CTO.
    Catheter Cardiovasc Interv. 2024;103:68-79.
    PubMed     Abstract available


    December 2023
  50. FISCHER J, Steffen J, Arlart T, Haum M, et al
    Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30927.
    PubMed     Abstract available


  51. HANSON I, Goldstein JA
    Percutaneous coronary intervention: Before, after, or during TAVR?
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30941.
    PubMed    


  52. AROW Z, Konigstein M, Vaknin-Assa H, Witberg G, et al
    Percutaneous coronary intervention with ridaforolimus eluting-stents in small vessel coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Dec 14. doi: 10.1002/ccd.30924.
    PubMed     Abstract available


  53. NOORI M, Christiansen EH, Raungaard B, Junker A, et al
    Long-term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Dec 13. doi: 10.1002/ccd.30937.
    PubMed     Abstract available


  54. BARBASH IM, Wasserstrum Y, Erlebach M, Guetta V, et al
    Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 7. doi: 10.1002/ccd.30921.
    PubMed     Abstract available


  55. PIEDIMONTE G, Azzalini L, Ferrarotto L, Mangione R, et al
    Applicability of J-CTO channel score to predict microcatheter tracking during retrograde percutaneous coronary intervention of chronic total occlusions: Insights from the SURFING MICRO registry.
    Catheter Cardiovasc Interv. 2023 Dec 4. doi: 10.1002/ccd.30928.
    PubMed     Abstract available


  56. DE SILVA K, Li Kam Wa ME, Wells T, Mozid A, et al
    The everolimus eluting Synergy Megatron(TM) drug-eluting stent platform: Early outcomes from the European Synergy Megatron(TM) Implanters' Registry.
    Catheter Cardiovasc Interv. 2023;102:1222-1228.
    PubMed     Abstract available


  57. BASAVARAJAIAH S, Kalkat H, Bhatia G, Cortese B, et al
    How to perform a successful drug-coated balloon angioplasty? Tips and tricks.
    Catheter Cardiovasc Interv. 2023;102:1238-1257.
    PubMed     Abstract available


  58. MOVAHED MR
    Movahed coronary bifurcation classification should be the preferred classification for studying true bifurcation lesions as it summarizes true bifurcation lesions in only one simple category called B2 Lesion with limitless optional suffixes.
    Catheter Cardiovasc Interv. 2023;102:1263-1264.
    PubMed    


  59. MATHEW RO, Rangaswami J, Abramov D, Mahalwar G, et al
    Proportional troponin changes and risk for outcomes with intervention strategies in non-ST-elevation acute coronary syndrome across kidney function.
    Catheter Cardiovasc Interv. 2023;102:1162-1176.
    PubMed     Abstract available


  60. YAYLAK B, Polat F, Onuk T, Akyuz S, et al
    The relation of polymer structure of stent used in patients with acute coronary syndrome revascularized by stent implantation with long-term cardiovascular events.
    Catheter Cardiovasc Interv. 2023;102:1186-1197.
    PubMed     Abstract available


  61. RAISZADEH M, Khosronejad A, Dianaty S, Yekta BG, et al
    Novel repair of acute Stanford type B aortic dissection using combined endovascular graft and transfemoral replacement of vascular plug.
    Catheter Cardiovasc Interv. 2023;102:1287-1290.
    PubMed     Abstract available


  62. SCHULTE K, Zdoroveac A, Gurke L, Isaak A, et al
    Endovascular maneuvers for contralateral stent graft limb misplacement in endovascular aortic repair.
    Catheter Cardiovasc Interv. 2023;102:1271-1274.
    PubMed     Abstract available


    November 2023
  63. JAVAID AI, Michalek JE, Gruslova AB, Hoskins SA, et al
    Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Nov 23. doi: 10.1002/ccd.30913.
    PubMed     Abstract available


  64. STEINBERG ZL, Rayner SG, Leary PJ
    Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension due to septic emboli.
    Catheter Cardiovasc Interv. 2023 Nov 22. doi: 10.1002/ccd.30919.
    PubMed     Abstract available


  65. GARBO R, Iannaccone M, Bruno F, Arioti M, et al
    Intravascular ultrasound-guided STAR 2.0: A new technique for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2023 Nov 20. doi: 10.1002/ccd.30920.
    PubMed     Abstract available


  66. SIMSEK B, Rempakos A, Kostantinis S, Alexandrou M, et al
    International survey of chronic total occlusion percutaneous coronary intervention operators.
    Catheter Cardiovasc Interv. 2023 Nov 20. doi: 10.1002/ccd.30914.
    PubMed     Abstract available


  67. MAJEED H, Blankenship JC
    Ellis type 4 coronary artery perforation during percutaneous coronary intervention: Case series and review.
    Catheter Cardiovasc Interv. 2023 Nov 10. doi: 10.1002/ccd.30873.
    PubMed     Abstract available


  68. NUMASAWA Y, Sawano M, Ishii H, Kohsaka S, et al
    One-year outcomes of patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy catheter: Insights from the J-PCI OUTCOME registry.
    Catheter Cardiovasc Interv. 2023 Nov 9. doi: 10.1002/ccd.30895.
    PubMed     Abstract available


  69. LIU X, Zhang Y, Xu Y, Tang Z, et al
    Fractional flow reserve versus intravascular imaging to guide decision-making for percutaneous coronary intervention in intermediate lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2023 Nov 8. doi: 10.1002/ccd.30909.
    PubMed     Abstract available


  70. COZZI O, Maurina M, Cacia M, Bernardini V, et al
    Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery.
    Catheter Cardiovasc Interv. 2023 Nov 7. doi: 10.1002/ccd.30903.
    PubMed     Abstract available


  71. ALADIN AI, Wermers JP, Zhang C, Case BC, et al
    Prognostic implication of hemoglobin reduction with and without clinical bleeding after percutaneous coronary intervention in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Nov 5. doi: 10.1002/ccd.30896.
    PubMed     Abstract available


  72. UNGUREANU C, Leone PP, Colletti G, Gasparini GL, et al
    Retrograde balloon hemostasis.
    Catheter Cardiovasc Interv. 2023;102:896-899.
    PubMed     Abstract available


  73. RISSANEN TT, Kleber FX, Scheller B
    Drug-coated balloon angioplasty is a well-established treatment and in everyday use in cathlabs worldwide.
    Catheter Cardiovasc Interv. 2023;102:912-913.
    PubMed    


  74. RESTIVO A, Stanzione A, Maffeo D, Buono A, et al
    Ping-pong snaring of a totally dislodged stent across left main ostium: "All is not lost".
    Catheter Cardiovasc Interv. 2023;102:889-891.
    PubMed     Abstract available


  75. FUJISAKI T, Kuno T, Iwagami M, Miyamoto Y, et al
    Net clinical benefit of dual antiplatelet therapy in elderly patients with acute coronary syndrome: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023;102:788-802.
    PubMed     Abstract available


  76. BLACHUTZIK F, Meier S, Weissner M, Schlattner S, et al
    Coronary intravascular lithotripsy and rotational atherectomy for severely calcified stenosis: Results from the ROTA.shock trial.
    Catheter Cardiovasc Interv. 2023;102:823-833.
    PubMed     Abstract available


  77. GALASSI AR, Vadala G, Maniscalco L, Gasparini G, et al
    Wire-based antegrade dissection re-entry technique for coronary chronic total occlusions percutaneous revascularization: Experience from the ERCTO Registry.
    Catheter Cardiovasc Interv. 2023;102:864-877.
    PubMed     Abstract available


  78. EL KHOURY A, Lazar L, Cortese B
    The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study.
    Catheter Cardiovasc Interv. 2023;102:979-986.
    PubMed     Abstract available


  79. SANDESARA PB, Elhage Hassan M, Shekiladze N, Turk AA, et al
    Intravascular lithotripsy compared to rotational atherectomy for the treatment of calcified distal left main coronary artery disease: A single center experience.
    Catheter Cardiovasc Interv. 2023;102:997-1003.
    PubMed     Abstract available


  80. HERRON C, Batlivala SP, Shahanavaz S
    Right atrial thrombus removal with use of the ONO retrieval device.
    Catheter Cardiovasc Interv. 2023;102:1105-1108.
    PubMed     Abstract available


  81. UEDA H, Fujiwara Y, Nishida Y, Maenaka M, et al
    Impact of prolonged drug-coated balloon inflation on residual stenosis and clinical outcomes in coronary artery disease patients: A propensity score matched analysis.
    Catheter Cardiovasc Interv. 2023;102:969-978.
    PubMed     Abstract available


  82. JUN EJ, Hong SP, Kim B, Lee JB, et al
    Healing and stent coverage with the new ultrathin sirolimus-eluting stent with abluminal biodegradable polymer.
    Catheter Cardiovasc Interv. 2023;102:1040-1047.
    PubMed     Abstract available


  83. WALLNER K, Kearney KE, Tiwana J, Pristera N, et al
    Increased prescription dose for large vessel intravascular brachytherapy.
    Catheter Cardiovasc Interv. 2023;102:1034-1039.
    PubMed     Abstract available


  84. CRITCHFIELD DR, Chamberlain RC, Turek JW, Fleming GA, et al
    Hybrid approach to pulmonary vein stenting after Fontan palliation.
    Catheter Cardiovasc Interv. 2023;102:1095-1100.
    PubMed     Abstract available


  85. ICHIKAWA M, Matsuoka Y, Hasebe T
    Coronary arterial repair in patients with stable angina pectoris or acute coronary syndrome after ultrathin biodegradable polymer sirolimus-eluting stent implantation at 1-year follow-up by coronary angioscopy.
    Catheter Cardiovasc Interv. 2023;102:1012-1019.
    PubMed     Abstract available


  86. MERINOPOULOS I, Gunawardena T, Corballis N, Tsampasian V, et al
    Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease.
    Catheter Cardiovasc Interv. 2023;102:987-996.
    PubMed     Abstract available


    October 2023
  87. MOHAMED MO, Kinnaird T, Rab ST, Zaman S, et al
    Intracoronary imaging guided percutaneous coronary intervention outcomes among individuals with cardiogenic shock.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30859.
    PubMed     Abstract available


  88. CORTESE B, Kalkat H, Bathia G, Basavarajaiah S, et al
    The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30891.
    PubMed     Abstract available


  89. LU H, Hu Y, Ma Y, Zhou Y, et al
    Exploring indicators of success in chronic total occlusion percutaneous coronary intervention with Stingray system-based antegrade dissection re-entry: Insights from retrospective analysis.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30889.
    PubMed     Abstract available


  90. HIGASHINO N, Iida O, Ishihara T, Hata Y, et al
    Angiographic patterns of restenosis after drug-coated balloon angioplasty for femoropopliteal lesions and 1-year prognosis after repeat endovascular therapy.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30856.
    PubMed     Abstract available


  91. AL MAWED M, Vlachojannis M, Pula A, Gielen S, et al
    Delayed coronary perforation four days after percutaneous coronary intervention with subsequent cardiac tamponade: A case report.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30861.
    PubMed     Abstract available


  92. MITSUI K, Takagi K, Kakuta T, Noguchi T, et al
    Novel percutaneous intervention technique for obstructed coronary artery after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30865.
    PubMed     Abstract available


  93. MAURINA M, Chiarito M, Leone PP, Testa L, et al
    Randomized clinical trial of abluminus DES+ sirolimus-eluting stent versus everolimus-eluting DES for percutaneous coronary intervention in patients with diabetes mellitus: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30853.
    PubMed     Abstract available


  94. PAOLUCCI L, De Micco F, Bezzeccheri A, Scarpelli M, et al
    Contrast media volume reduction with the DyeVert(TM) system to prevent acute kidney injury in stable patients undergoing coronary procedures.
    Catheter Cardiovasc Interv. 2023;102:655-662.
    PubMed     Abstract available


  95. TENG L, Zhang Y, Fang J, Liu X, et al
    A Bayesian network meta-analysis for acute thrombosis after lower extremity artery endovascular treatment.
    Catheter Cardiovasc Interv. 2023;102:731-742.
    PubMed     Abstract available


  96. GRESSLER LE, Ramkumar N, Marinac-Dabic D, dosReis S, et al
    The association of major adverse limb events and combination stent and atherectomy in patients undergoing revascularization for lower extremity peripheral artery disease.
    Catheter Cardiovasc Interv. 2023;102:688-700.
    PubMed     Abstract available


  97. HIRAI T
    "Crossing the invisible".
    Catheter Cardiovasc Interv. 2023;102:774-775.
    PubMed    


  98. KLEBER FX
    Commentary: Dissection still a sticking point in the widespread use of DCB in PCI.
    Catheter Cardiovasc Interv. 2023;102:772-773.
    PubMed    


  99. SCHLEIGER A, Al Darwish N, Meyer M, Kramer P, et al
    Long-term follow-up after endovascular treatment of aortic coarctation with bare and covered Cheatham platinum stents.
    Catheter Cardiovasc Interv. 2023;102:672-682.
    PubMed     Abstract available


    September 2023
  100. SHAMKHANI W, Moledina S, Rashid M, Mamas MA, et al
    Complex high-risk percutaneous coronary intervention types, trends, and outcomes according to vascular access site.
    Catheter Cardiovasc Interv. 2023 Sep 26. doi: 10.1002/ccd.30846.
    PubMed     Abstract available


  101. DI MAIO M, Esposito L, Silverio A, Bellino M, et al
    Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 13. doi: 10.1002/ccd.30842.
    PubMed     Abstract available


  102. ULLAH W, Sarvepalli D, Kumar A, Zahid S, et al
    Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysis.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30832.
    PubMed     Abstract available


  103. AHN J, Yu H, Rha SW, Choi BG, et al
    Long-term clinical outcomes following successful percutaneous coronary intervention in patients with extremely long coronary chronic total occlusion lesions.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30829.
    PubMed     Abstract available


  104. REMPAKOS A, Kostantinis S, Simsek B, Karacsonyi J, et al
    Impact of preprocedural anemia on in-hospital and follow-up outcomes of chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30810.
    PubMed     Abstract available


  105. HIRAI T, Grantham JA, Kandzari DE, Ballard W, et al
    Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30834.
    PubMed     Abstract available


  106. ALEXANDROU M, Rempakos A, Al Ogaili A, Choi JW, et al
    Balloon-assisted subintimal entry (BASE) in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30830.
    PubMed     Abstract available


  107. SOMSEN YBO, de Winter RW, Giunta R, Schumacher SP, et al
    Collateral grading systems in retrograde percutaneous coronary intervention of chronic total occlusions.
    Catheter Cardiovasc Interv. 2023 Sep 6. doi: 10.1002/ccd.30812.
    PubMed     Abstract available


  108. BRUNO F, Kang J, Elia E, Han JK, et al
    Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30802.
    PubMed     Abstract available


  109. SCARPARO P, Schermers T, Improta R, Kardys I, et al
    Stent expansion in calcified coronary chronic total occlusions: The impact of different stent platforms.
    Catheter Cardiovasc Interv. 2023;102:451-463.
    PubMed     Abstract available


  110. VAZQUEZ DJL, Lopez GA, Guzman MQ, Cancelo AV, et al
    Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure.
    Catheter Cardiovasc Interv. 2023;102:513-520.
    PubMed     Abstract available


  111. KIM SE, Choi KH, Song YB
    An unusual no-reflow phenomenon due to neointimal tissue embolization during drug eluting balloon intervention in stent restenosis: A case report.
    Catheter Cardiovasc Interv. 2023;102:481-485.
    PubMed     Abstract available


  112. DOOLUB G, Iannaccone M, Rab T, Routledge H, et al
    Sex-based treatment and outcomes for coronary bifurcation stenting: A report from the e-ULTIMASTER registry.
    Catheter Cardiovasc Interv. 2023;102:430-439.
    PubMed     Abstract available


  113. VELLA C, Preda A, Ferri L, Montorfano M, et al
    Intravascular coronary lithotripsy for the treatment of iatrogenic calcium embolization: The "block and crack" technique.
    Catheter Cardiovasc Interv. 2023;102:486-488.
    PubMed     Abstract available


    August 2023
  114. SUZUKI N
    Prediction of residual ischemia after coronary stenting by quantitative flow ratio modulated by optical coherence tomography: Where we are now and our future perspectives.
    Catheter Cardiovasc Interv. 2023;102:392-393.
    PubMed    


  115. CHAUS A, Uretsky BF
    "CHIP-ping" away at the definition of PCI "complexity" and "risk".
    Catheter Cardiovasc Interv. 2023;102:396-397.
    PubMed    


  116. SHROFF GR, Garcia S, Schmidt C, Okeson B, et al
    Renal impairment and mortality in patients with STEMI and cardiogenic shock/cardiac arrest.
    Catheter Cardiovasc Interv. 2023;102:179-190.
    PubMed     Abstract available


  117. YASSIN I, Mosaad MA, Hassan AM, Abdelghani M, et al
    Fix and pull technique for retrieval of intracoronary unexpanded-stent entrapment.
    Catheter Cardiovasc Interv. 2023;102:247-248.
    PubMed     Abstract available


    July 2023
  118. SUN ML, Zhu YJ, Zhou YP, Zhu XJ, et al
    Percutaneous transluminal pulmonary angioplasty for Takayasu arteritis-associated pulmonary hypertension: A single-arm meta-analysis.
    Catheter Cardiovasc Interv. 2023 Jul 31. doi: 10.1002/ccd.30773.
    PubMed     Abstract available


  119. KANDZARI DE, Garcia-Garcia HM, Stoler RC, Wang J, et al
    Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30783.
    PubMed     Abstract available


  120. GINETE WL, Groth NA, Rudeck MN, Renier CM, et al
    Outcomes of same-day discharge following percutaneous coronary intervention in a rural population.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30762.
    PubMed     Abstract available


  121. PARK DY, An S, Jolly N, Attanasio S, et al
    Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30784.
    PubMed     Abstract available


  122. SONODA S, Node K
    Fighting calcification with optical coherence tomography-guided percutaneous coronary intervention. Commentary on the optical coherence tomography-derived predictors of stent expansion in calcified lesions.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30776.
    PubMed    


  123. AIJAZ B, Glorioso TJ, Butala N, Waldo SW, et al
    Temporal trends and hospital variation in the use of P2Y12 inhibitors among patients undergoing percutaneous coronary intervention: Insights from the VA CART program.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30782.
    PubMed    


  124. MAZNYCZKA A, Arunothayaraj S, Egred M, Banning A, et al
    Bifurcation left main stenting with or without intracoronary imaging: Outcomes from the EBC MAIN trial.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30785.
    PubMed     Abstract available


  125. KANE J, Kearney KE, Lombardi WL, Azzalini L, et al
    Electrocautery-assisted re-entry to resolve bilateral aorto-ostial chronic total occlusions due to leaflet obstruction following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30781.
    PubMed     Abstract available


  126. MITSUI K, Lee T, Miyazaki R, Hara N, et al
    Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
    Catheter Cardiovasc Interv. 2023;102:11-17.
    PubMed     Abstract available


  127. ZIEDSES DES PLANTES AC, Scoccia A, Neleman T, Groenland FTW, et al
    Optical coherence tomography-derived predictors of stent expansion in calcified lesions.
    Catheter Cardiovasc Interv. 2023;102:25-35.
    PubMed     Abstract available


  128. WERNER GS, Lorenz S, Dimitriadis Z, Krueger B, et al
    Anemia and periprocedural complications determine contrast-associated acute kidney injury after recanalization of chronic coronary occlusions in chronic kidney disease.
    Catheter Cardiovasc Interv. 2023;102:101-110.
    PubMed     Abstract available


    June 2023
  129. GEWEHR DM, Carvalho PEP, Dagostin CS, Cardoso R, et al
    Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Jun 23. doi: 10.1002/ccd.30750.
    PubMed     Abstract available


  130. PICCOLO R, Leone A, Simonetti F, Avvedimento M, et al
    Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jun 19. doi: 10.1002/ccd.30749.
    PubMed     Abstract available


  131. LOPEZ-MINGUEZ JR, Martin de Francisco AL, Soler MJ, Hernandez F, et al
    Cost-effectiveness analysis of dyevert Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain.
    Catheter Cardiovasc Interv. 2023 Jun 10. doi: 10.1002/ccd.30744.
    PubMed     Abstract available


  132. MILEVA N, Ohashi H, Paolisso P, Leipsic J, et al
    Relationship between coronary volume, myocardial mass, and post-PCI fractional flow reserve.
    Catheter Cardiovasc Interv. 2023;101:1182-1192.
    PubMed     Abstract available


  133. PERSHAD A
    CTO revascularization in TAVR patients-The jury is still out.
    Catheter Cardiovasc Interv. 2023;101:1229.
    PubMed    


  134. ZONI CR, Mukherjee D, Gulati M
    Proposed new classification for acute coronary syndrome: Acute coronary syndrome requiring immediate reperfusion.
    Catheter Cardiovasc Interv. 2023;101:1177-1181.
    PubMed    


    May 2023
  135. GROENLAND FTW, Ziedses des Plantes AC, Neleman T, Scoccia A, et al
    Culprit lesion plaque characterization and thrombus grading by high-definition intravascular ultrasound in patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30699.
    PubMed     Abstract available


  136. DE FILIPPO O, Bruno F, Pinxterhuis TH, Gasior M, et al
    Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30696.
    PubMed     Abstract available


  137. RJOOB K, McGilligan V, McAllister R, Bond R, et al
    What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30684.
    PubMed     Abstract available


  138. BENEDETTI A, Castaldi G, Poletti E, Moroni A, et al
    Percutaneous treatment of left circumflex coronary artery injury related to mitral valve surgery: Case series and systematic review of the literature.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30693.
    PubMed     Abstract available


  139. OKSNES A, Skaar E, Engan B, Bleie O, et al
    Effectiveness, safety, and patient reported outcomes of a planned investment procedure in higher-risk chronic total occlusion percutaneous coronary intervention: Rationale and design of the invest-CTO study.
    Catheter Cardiovasc Interv. 2023 May 17. doi: 10.1002/ccd.30692.
    PubMed     Abstract available


  140. DING D, Tu S, Li Y, Li C, et al
    Quantitative flow ratio modulated by intracoronary optical coherence tomography for predicting physiological efficacy of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30681.
    PubMed     Abstract available


  141. GHETTI G, Bendandi F, Donati F, Ciurlanti L, et al
    Predictors of bail-out stenting in patients with small vessel disease treated with drug-coated balloon percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30688.
    PubMed     Abstract available


  142. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Aortocoronary dissection during percutaneous coronary interventions for chronic total occlusion: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30680.
    PubMed     Abstract available


  143. ZHANG YJ, Ma WR, Xu B, Huang ZH, et al
    Retrograde percutaneous coronary intervention of chronic total occlusion via discontinuous septal channels.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30678.
    PubMed     Abstract available


  144. CADER A, Alasnag M
    Is there a woman paradox? Commentary on the Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 May 8. doi: 10.1002/ccd.30672.
    PubMed    


  145. ABRAHAM B, Farina JM, Fath A, Abdou M, et al
    The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2023 May 5. doi: 10.1002/ccd.30676.
    PubMed     Abstract available


  146. MINICI R, Serra R, De Rosi N, Ciranni S, et al
    Endovascular treatment of femoro-popliteal occlusions with retrograde tibial access after failure of the antegrade approach.
    Catheter Cardiovasc Interv. 2023;101:1108-1119.
    PubMed     Abstract available


  147. RIGATTIERI S, Casenghi M
    Lowering air kerma to improve the CTO operator's karma.
    Catheter Cardiovasc Interv. 2023;101:1172-1173.
    PubMed    


  148. MORONI A, Marin F, Venturi G, Scarsini R, et al
    Management of failed stenting of the unprotected left main coronary artery.
    Catheter Cardiovasc Interv. 2023;101:1001-1013.
    PubMed     Abstract available


  149. MASSUSSI M, Adamo M, Rosati F, Chizzola G, et al
    Coronary artery disease and TAVI: Current evidence on a recurrent issue.
    Catheter Cardiovasc Interv. 2023;101:1154-1160.
    PubMed     Abstract available


  150. BUYUKGOZ C, Sandhu H, Shah S, Rower K, et al
    Strategies and techniques for percutaneous Veno-Arterial ECMO cannulation and decannulation in children.
    Catheter Cardiovasc Interv. 2023;101:1088-1097.
    PubMed     Abstract available


  151. MORETTI F, Rondi M, Ottani F
    Zero-contrast IVUS-guided complex PCI in a patient with NSTE-ACS and severe renal impairment.
    Catheter Cardiovasc Interv. 2023;101:1074-1080.
    PubMed     Abstract available


  152. YIN J, Wang R, Chen H, Lu H, et al
    In vivo evaluation of intravascular lithotripsy in a healthy porcine coronary model.
    Catheter Cardiovasc Interv. 2023;101:1062-1070.
    PubMed     Abstract available


  153. NICKELL A, Sergev O, Alberto N, Bande D, et al
    Effectiveness of the vacuum assisted aspiration AngioVac system in the removal of intravascular masses.
    Catheter Cardiovasc Interv. 2023;101:1161-1165.
    PubMed     Abstract available


  154. SETO AH
    Cut, score, press, shock, or ablate?
    Catheter Cardiovasc Interv. 2023;101:975-977.
    PubMed    


  155. EL HAJJ M, Krajcer Z
    Bioresorbable stents: We have more work to do.
    Catheter Cardiovasc Interv. 2023;101:978-979.
    PubMed    


  156. WANG X, Li Y, Fu G, Xu B, et al
    Three-year clinical outcomes of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient-level pooled analysis of NeoVas trials.
    Catheter Cardiovasc Interv. 2023;101:967-972.
    PubMed     Abstract available


    April 2023
  157. TARANTINI G, Cardaioli F
    Looking but not seeing the cap: The case for PROGRESS-CTO.
    Catheter Cardiovasc Interv. 2023;101:955-956.
    PubMed    


  158. GRINES CL, Tummala PE
    Calcified coronary nodule: Tip of the iceberg on a road full of thorns.
    Catheter Cardiovasc Interv. 2023;101:959-960.
    PubMed    


  159. RAMKUMAR N, Suckow BD, Behrendt CA, Mackenzie TA, et al
    Association between sex and long-term outcomes of endovascular treatment for peripheral artery disease.
    Catheter Cardiovasc Interv. 2023;101:877-887.
    PubMed     Abstract available


  160. LONG Y, He B, Tsao N, Liu H, et al
    Combined ascending aortobiiliac bypass and endovascular obliteration in the Bentall procedure for dual aortic aneurysms.
    Catheter Cardiovasc Interv. 2023;101:943-946.
    PubMed     Abstract available


  161. YILDIZ M, Henry TD
    Unprotected left main occlusion: Rare but deadly.
    Catheter Cardiovasc Interv. 2023;101:953-954.
    PubMed    


  162. ANDREA E, Danilo M, Nicola GA, Pierluigi CA, et al
    Adjunctive techniques in endovascular repair of postcarotid endarterectomy pseudoaneurysm: Case report and literature review.
    Catheter Cardiovasc Interv. 2023;101:900-906.
    PubMed     Abstract available


  163. JIA H, Xi Y, Yuan P, Guo W, et al
    Coil embolization of asymptomatic left gastric artery aneurysm: Case report and literature review.
    Catheter Cardiovasc Interv. 2023;101:907-910.
    PubMed     Abstract available


  164. MUSUMECI G, Annibali G
    Keep it simple.
    Catheter Cardiovasc Interv. 2023;101:947-948.
    PubMed    


  165. MORI S, Takahara M, Nakama T, Tobita K, et al
    Impact of calcification on clinical outcomes after drug-coated balloon angioplasty for superficial femoral artery disease: Assessment using the peripheral artery calcification scoring system.
    Catheter Cardiovasc Interv. 2023;101:892-899.
    PubMed     Abstract available


  166. ZACA S, Patruno I, Pulli R, Angiletta D, et al
    Endovascular repair using parallel grafts to treat a suprarenal pancreatitis-related abdominal aortic pseudoaneurysm.
    Catheter Cardiovasc Interv. 2023;101:888-891.
    PubMed     Abstract available


  167. HADDAD RN, Dautry R, Bonnet D, Malekzadeh-Milani S, et al
    Transvenous retrograde thoracic duct embolization for effective treatment of recurrent plastic bronchitis after fontan palliation.
    Catheter Cardiovasc Interv. 2023;101:863-869.
    PubMed     Abstract available


  168. BACCI E, Chiarito M, Sanz-Sanchez J, Leone PP, et al
    Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2023;101:911-917.
    PubMed     Abstract available


  169. HANNAN EL, Zhong Y, Cozzens K, Osinaga A, et al
    Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New York.
    Catheter Cardiovasc Interv. 2023 Apr 1. doi: 10.1002/ccd.30648.
    PubMed     Abstract available


    March 2023
  170. TORABI AJ, Von der Lohe E, Kovacs RJ, Frick KA, et al
    Measures of social deprivation and outcomes after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30642.
    PubMed     Abstract available


  171. SIMSEK B, Khatri J, Young L, Kostantinis S, et al
    Same day discharge versus overnight observation following chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Mar 24. doi: 10.1002/ccd.30644.
    PubMed     Abstract available


  172. MORI H, Kurita T, Takasaki A, Dohi K, et al
    Plaque characterization of a saphenous vein graft by near-infrared spectroscopy and histopathology in a patient with a percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30641.
    PubMed     Abstract available


  173. RYAN N, Alasnag M
    Commentary on "Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry".
    Catheter Cardiovasc Interv. 2023 Mar 21. doi: 10.1002/ccd.30643.
    PubMed    


  174. ALLANA SS, Brilakis ES
    What is the role of drug-coated balloons in chronic total occlusion percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30632.
    PubMed    


  175. DAI N, Tang X, Chen Z, Huang D, et al
    Pre-stenting angiography-FFR based physiological map provides virtual intervention and predicts physiological and clinical outcomes.
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30635.
    PubMed     Abstract available


  176. KIM YH, Her AY, Rha SW, Choi CU, et al
    Effects of delayed hospitalization on the 3-year clinical outcomes of patients with or without diabetes who had non-ST-segment-elevation myocardial infarction and underwent new-generation drug-eluting stent implantation.
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30630.
    PubMed     Abstract available


  177. AVRAN A, Zuffi A, Gobbi C, Gasperetti A, et al
    Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30616.
    PubMed     Abstract available


  178. POSTALIAN A, Krajcer Z
    The relationship between chronic kidney disease and "complex" percutaneous coronary intervention: Uncovering the details.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30612.
    PubMed    


  179. TOKUDA T, Oba Y, Kagase A, Matsuda H, et al
    Feasibility and impact of extra-vascular ultrasound-guided endovascular treatment for infrapopliteal artery occlusive disease.
    Catheter Cardiovasc Interv. 2023 Mar 6. doi: 10.1002/ccd.30615.
    PubMed     Abstract available


  180. LEE A, Gilchrist IC
    A tale of two registries: Trends and outcomes of percutaneous coronary intervention in two transatlantic populations.
    Catheter Cardiovasc Interv. 2023 Mar 2. doi: 10.1002/ccd.30608.
    PubMed    


  181. HEUSER RR
    Regulators can we get DCB balloons approved for use in the United States?
    Catheter Cardiovasc Interv. 2023;101:834-835.
    PubMed    


  182. SETO AH, Tehrani DM
    Better together? Maybe not with CTO-PCI.
    Catheter Cardiovasc Interv. 2023;101:828-829.
    PubMed    


  183. MANGIERI A, Nerla R, Castriota F, Reimers B, et al
    Cutting balloon to optimize predilation for stent implantation: The COPS randomized trial.
    Catheter Cardiovasc Interv. 2023;101:798-805.
    PubMed     Abstract available


  184. MATSUHIRO Y, Nakamura D, Dohi T, Ishihara T, et al
    Impact of calcified nodule on target lesion failure after stent implantation in hemodialysis patients.
    Catheter Cardiovasc Interv. 2023;101:701-712.
    PubMed     Abstract available


  185. FEGHALY J, Chen K, Blanco A, Pineda AM, et al
    Distal versus conventional radial artery access for coronary catheterization: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023;101:722-736.
    PubMed     Abstract available


  186. TERASHITA K, Shimada Y, Yamanaka Y, Motohashi Y, et al
    Intraplaque wiring enables drug-coated balloons to be utilized for percutaneous recanalization of chronically occluded coronary arteries.
    Catheter Cardiovasc Interv. 2023;101:764-772.
    PubMed     Abstract available


  187. DURIG M, Arroyo D, Bedossa M, Commeau P, et al
    Clinical outcomes after unprotected left main coronary artery occlusion: A retrospective multicentre cohort analysis.
    Catheter Cardiovasc Interv. 2023;101:679-686.
    PubMed     Abstract available


  188. LI WD, Keyoumu R, Wang C, Liu Z, et al
    3D Printing-guided endovascular repair of enormous twisted thoracoabdominal aortic aneurysm with branch stenosis and occlusion.
    Catheter Cardiovasc Interv. 2023;101:813-816.
    PubMed     Abstract available


  189. ANDREASEN LN, Balleby IR, Barkholt TO, Hebsgaard L, et al
    Early healing after treatment of coronary lesions by thin strut everolimus, or thicker strut biolimus eluting bioabsorbable polymer stents: The SORT-OUT VIII OCT study.
    Catheter Cardiovasc Interv. 2023;101:787-797.
    PubMed     Abstract available


    February 2023
  190. UENO K, Morita N, Kojima Y, Takahashi H, et al
    Serial quantitative angiographic study of target lumen enlargement after drug-coated balloon angioplasty for native coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Feb 25. doi: 10.1002/ccd.30598.
    PubMed     Abstract available


  191. IGLESIAS JF, Muller O, Losdat S, Roffi M, et al
    Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized t
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30600.
    PubMed     Abstract available


  192. HEATON J, Singh S, Nanavaty D, Okoh AK, et al
    Impact of frailty on outcomes in acute ST-elevated myocardial infarctions undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30595.
    PubMed     Abstract available


  193. WILL M, Schwarz K, Weiss T, Leibundgut G, et al
    The impact of chronic total occlusions in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30601.
    PubMed     Abstract available


  194. REMPAKOS A, Simsek B, Kostantinis S, Karacsonyi J, et al
    Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30581.
    PubMed     Abstract available


  195. KOSTANTINIS S, Simsek B, Karacsonyi J, Rempakos A, et al
    Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30580.
    PubMed     Abstract available


  196. WANAMAKER BL, Shoaib A, Seth M, Sukul D, et al
    Comparative analysis of percutaneous revascularization practice in the United States and the United Kingdom: Insights from the BMC2 and BCIS databases.
    Catheter Cardiovasc Interv. 2023;101:495-504.
    PubMed     Abstract available


  197. ARUNOTHAYARAJ S, Lassen JF, Clesham GJ, Spence MS, et al
    Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial.
    Catheter Cardiovasc Interv. 2023;101:553-562.
    PubMed     Abstract available


  198. AZZALINI L, Hirai T, Salisbury A, Gosch K, et al
    Validation of the new PROGRESS-CTO complication risk scores in the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2023;101:536-542.
    PubMed     Abstract available


  199. VAN HEMERT ND, Voskuil M, Rozemeijer R, Kraaijeveld AO, et al
    Long-term follow-up of contemporary drug-eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial.
    Catheter Cardiovasc Interv. 2023;101:505-510.
    PubMed     Abstract available


    January 2023
  200. KARACSONYI J, Alaswad K, Krestyaninov O, Karmpaliotis D, et al
    Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Jan 25. doi: 10.1002/ccd.30564.
    PubMed     Abstract available


  201. KAWAMURA Y, Yoshimachi F, Kasai S, Ikari Y, et al
    Novel dual guiding catheter technique for kissing balloon inflation in percutaneous coronary intervention for bifurcated chronic total occlusive lesion.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30568.
    PubMed     Abstract available


  202. CHEN H, Spirito A, Sartori S, Nicolas J, et al
    Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30569.
    PubMed     Abstract available


  203. RASANEN A, Karkkainen JM, Eranti A, Eranen J, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30558.
    PubMed     Abstract available


  204. AZZALINI L, Boudou N, Avran A, Kane J, et al
    Role of the retrograde Carlino technique for chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30565.
    PubMed     Abstract available


  205. DAVIS MG, Blankenship JC
    PCI for late STEMI: Better late than never?
    Catheter Cardiovasc Interv. 2023;101:11-12.
    PubMed    


  206. CHAUS A, Uretsky BF
    Bifurcation stenting: If the shoe doesn't fit.
    Catheter Cardiovasc Interv. 2023;101:58-59.
    PubMed    


  207. SAQIB N, Pir MS, Rajagopalan S, Patel TM, et al
    Comparison of radiation exposure associated with transradial and transfemoral access: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2023;101:87-96.
    PubMed     Abstract available


  208. PETKOSKA D, Zafirovska B, Vasilev I, Novotni G, et al
    Radial and ulnar approach for carotid artery stenting with Roadsaver double layer micromesh stent: Early and long-term follow-up.
    Catheter Cardiovasc Interv. 2023;101:154-163.
    PubMed     Abstract available


  209. INCI EK, Khandhar S, Toma C, Licitra G, et al
    Mechanical thrombectomy versus catheter directed thrombolysis in patients with pulmonary embolism: A multicenter experience.
    Catheter Cardiovasc Interv. 2023;101:140-146.
    PubMed     Abstract available


  210. GRIFFIN ACG, Yildiz M, Bradley S, Smith JE, et al
    Frequency and outcomes of STEMI patients presenting between 12 and 24 h after symptom onset: Late-presenting STEMI.
    Catheter Cardiovasc Interv. 2023;101:1-10.
    PubMed     Abstract available


  211. PRICE J, Okyere R, Al-Kindi S, Gupta A, et al
    Management of a right coronary artery mycotic coronary aneurysm with percutaneous intervention with covered stents.
    Catheter Cardiovasc Interv. 2023;101:108-112.
    PubMed     Abstract available


  212. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
    Catheter Cardiovasc Interv. 2023;101:13-21.
    PubMed     Abstract available


  213. GAROT P, Brunel P, Dibie A, Morelle JF, et al
    Comparison of outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The BioFreedom France study.
    Catheter Cardiovasc Interv. 2023;101:60-71.
    PubMed     Abstract available


  214. ACHIM A, Krivoshei L, Leibundgut G
    Unrecoverable stent deformation in the left main: Crush it or remove it?
    Catheter Cardiovasc Interv. 2023;101:113-120.
    PubMed     Abstract available


  215. CHIANG M, Villablanca PA, O'Neill WW, Frisoli T, et al
    Trans-caval aspiration artherectomy/thrombectomy of large mobile plaques and thrombi in aortic arch and descending aorta.
    Catheter Cardiovasc Interv. 2023;101:164-169.
    PubMed     Abstract available


    December 2022
  216. QIAN J, Wu Y, Li C, Yin J, et al
    Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study.
    Catheter Cardiovasc Interv. 2022 Dec 8. doi: 10.1002/ccd.30472.
    PubMed     Abstract available


  217. TEHRANI DM, Seto AH
    The future of angiography: Estimates of FFR pre- and post-PCI.
    Catheter Cardiovasc Interv. 2022;100:1218-1219.
    PubMed    


  218. FARIA D, Mejia-Renteria H, Lee JM, Lee SH, et al
    Age-related changes in the coronary microcirculation influencing the diagnostic performance of invasive pressure-based indices and long-term patient prognosis.
    Catheter Cardiovasc Interv. 2022;100:1195-1205.
    PubMed     Abstract available


  219. THALER C, Witt DR, Henry TD, Grey EZ, et al
    Revascularization and long-term outcomes in high-acuity spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2022;100:1229-1241.
    PubMed     Abstract available


  220. WINSCOTT JG, Hillegass WB
    Drug-coated balloon treatment of complex femoropopliteal disease yields favorable and durable outcomes at 5 years.
    Catheter Cardiovasc Interv. 2022;100:1284-1285.
    PubMed    


  221. KO YG, Choi D, Rha SW, Won JH, et al
    Long-term outcomes after paclitaxel-coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study.
    Catheter Cardiovasc Interv. 2022;100:1273-1283.
    PubMed     Abstract available


    November 2022
  222. NG JCK, Ang H, Zhong L, Hakim D, et al
    Multimodality imaging results of TAP versus novel modified TAP stenting in coronary bifurcation: From bench testing to first-in-man investigation.
    Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30496.
    PubMed     Abstract available


  223. AZZALINI L, Moroni F, Dawson KL, Kearney KE, et al
    Chronic total occlusion percutaneous coronary intervention in heart transplant patients.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30476.
    PubMed     Abstract available


  224. NAGRAJ S, Tzoumas A, Kakargias F, Giannopoulos S, et al
    Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): A meta-analysis of 14 studies comprising 4226 patients.
    Catheter Cardiovasc Interv. 2022 Nov 6. doi: 10.1002/ccd.30446.
    PubMed     Abstract available


  225. SELVARAJ V, Chatterjee S, Hirai T, Abbott JD, et al
    Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2022 Nov 3. doi: 10.1002/ccd.30467.
    PubMed     Abstract available


  226. SCOCCIA A, Scarparo P, Neleman T, Kakar H, et al
    Diagnostic accuracy of angiography-based vessel fractional flow reserve after chronic coronary total occlusion recanalization.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30439.
    PubMed     Abstract available


  227. LEE HJ, Mejia-Renteria H, Escaned J, Doh JH, et al
    Prediction of functional results of percutaneous coronary interventions with virtual stenting and quantitative flow ratio.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30451.
    PubMed     Abstract available


  228. TARANTINI G, Cardaioli F
    CHIP-PCI: Ready for a prime time?
    Catheter Cardiovasc Interv. 2022;100:721-722.
    PubMed    


  229. ALLANA SS, Brilakis ES
    How good is intravascular brachytherapy for treating in-stent restenosis?
    Catheter Cardiovasc Interv. 2022;100:763-764.
    PubMed    


  230. CILINGIROGLU M, Halil Inanc I
    Local or general anesthesia for EVAR in patients with ruptured AAA?
    Catheter Cardiovasc Interv. 2022;100:938.
    PubMed    


  231. COLOPI M, Musumeci G
    Intravascular lithotripsy pretreatment of coronary chronic total occlusions: Current PROGRESS and the Next Frontier.
    Catheter Cardiovasc Interv. 2022;100:939-940.
    PubMed    


  232. WINSCOTT JG, Hillegass WB
    Percutaneous coronary intervention in the polyvascular patient remains a high-risk procedure.
    Catheter Cardiovasc Interv. 2022;100:747-748.
    PubMed    


  233. TOPAZ O
    The premise and performance of transcatheter vacuum-assisted extraction of left side cardiac thrombotic masses.
    Catheter Cardiovasc Interv. 2022;100:931-932.
    PubMed    


  234. ALLANA SS, Brilakis ES
    Dual guidewire balloon for antegrade fenestration re-entry: A welcome addition to the CTO operators' armamentarium.
    Catheter Cardiovasc Interv. 2022;100:933-935.
    PubMed    


  235. JONES EL, Blankenship JC
    Women deserve the best care.
    Catheter Cardiovasc Interv. 2022;100:936-937.
    PubMed    


  236. KUKAR A, Dangas GD
    Peripheral studies deserve center stage!
    Catheter Cardiovasc Interv. 2022;100:927-928.
    PubMed    


  237. SIMSEK B, Kostantinis S, Karacsonyi J, Allana S, et al
    Outcomes and challenges of the provisional stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;100:749-755.
    PubMed     Abstract available


  238. WALLNER K, Kearney KE, Kim M, Tiwana J, et al
    Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.
    Catheter Cardiovasc Interv. 2022;100:759-762.
    PubMed     Abstract available


  239. CHAMI T, Mahowald MK, Brilakis E
    Retrograde approach for rewiring a jailed side branch during double kissing crush stenting.
    Catheter Cardiovasc Interv. 2022;100:756-758.
    PubMed     Abstract available


  240. TARGONSKI R, Gasecka A, Luis MS, Jagielak D, et al
    Harnessing the parallax for better spatial awareness.
    Catheter Cardiovasc Interv. 2022;100:915-922.
    PubMed     Abstract available


  241. YEN YT, Chen YY, Kao PH, Lin CH, et al
    Zone 0 thoracic endovascular aortic repair in high risk patients: A retrospective case series.
    Catheter Cardiovasc Interv. 2022;100:787-794.
    PubMed     Abstract available


  242. TARANTINI G, Fabris T
    Single-access technique for Impella-assisted PCI: How to take hold of Impella by the smooth handle.
    Catheter Cardiovasc Interv. 2022;100:1043-1044.
    PubMed    


  243. PICCOLO R, Esposito G
    Peripheral arterial disease and multisite atherosclerosis in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100:1146-1147.
    PubMed    


  244. SETH A, Ezhumalai B
    Percutaneous Coronary Intervention of bifurcation lesions: The proof is in the pudding!
    Catheter Cardiovasc Interv. 2022;100:1148-1149.
    PubMed    


  245. SALAETS T, Cools B, De Meester P, Heying R, et al
    Stent expansion of restrictive Fontan conduits to nominal diameter and beyond.
    Catheter Cardiovasc Interv. 2022;100:1059-1066.
    PubMed     Abstract available


  246. ALLALI A, Toelg R, Abdel-Wahab M, Hemetsberger R, et al
    Combined rotational atherectomy and cutting balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions: The PREPARE-CALC-COMBO study.
    Catheter Cardiovasc Interv. 2022;100:979-989.
    PubMed     Abstract available


  247. GILLMORE T, Jung RG, Moreland R, Di Santo P, et al
    Impact of intracoronary assessments on revascularization decisions: A contemporary evaluation.
    Catheter Cardiovasc Interv. 2022;100:955-963.
    PubMed     Abstract available


  248. MASUDA H, Kuramitsu S, Ito T, Morofuji T, et al
    Outcomes of paclitaxel-coated balloon angioplasty for in-stent calcified nodule: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2022;100:990-999.
    PubMed     Abstract available


  249. ROLA P, Wlodarczak S, Doroszko A, Lesiak M, et al
    The bioresorbable magnesium scaffold (Magmaris)-State of the art: From basic concept to clinical application.
    Catheter Cardiovasc Interv. 2022;100:1051-1058.
    PubMed     Abstract available


  250. LANGHOFF R, Petrov I, Kedev S, Milosevic Z, et al
    PERFORMANCE 1 study: Novel carotid stent system with integrated post-dilation balloon and embolic protection device.
    Catheter Cardiovasc Interv. 2022;100:1090-1099.
    PubMed     Abstract available


  251. DEL VAL D, Cuesta J, Roquero P, Alfonso F, et al
    Lithotripsy for calcified in-stent restenosis. The "rock strata peeling pattern": A novel fracture pattern detected by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;100:1036-1038.
    PubMed     Abstract available


  252. PARFREY S, Mozid A
    Feasibility of facilitated antegrade dissection with Stingray-based re-entry for coronary chronic total occlusions with previously stented graft-to-native-vessel anastomoses.
    Catheter Cardiovasc Interv. 2022;100:1030-1035.
    PubMed     Abstract available


  253. MORETTI F, Bernelli C, Pellegrini D, Boccuzzi G, et al
    Determinants and long-term outcomes of largely uncovered struts in thin-struts drug-eluting stents assessed by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S25-S35.
    PubMed     Abstract available


  254. BUCCOLA J, Meinen J, Spinelli J, Hammerstone M, et al
    Investigating real-world impact of optical coherence tomography workflow-guided coronary interventions: Design and rationale of the LightLab Clinical Initiative.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S1-S6.
    PubMed     Abstract available


  255. SHLOFMITZ E, Croce K, Bezerra H, Sheth T, et al
    The MLD MAX OCT algorithm: An imaging-based workflow for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S7-S13.
    PubMed     Abstract available


  256. RAJA A, Osborn EA, Bergmark BA, Croce KD, et al
    OCT utilization: Summary statistics from the LightLab clinical initiative.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S36-S43.
    PubMed     Abstract available


  257. KHUDDUS MA, Darki A, Padaliya BB, West NEJ, et al
    Improving efficiency and operator proficiency during percutaneous coronary interventions utilizing a standardized optical coherence tomography workflow.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S14-S24.
    PubMed     Abstract available


    October 2022
  258. WATANABE Y, Sakakura K, Taniguchi Y, Yamamoto K, et al
    Impact of intravascular ultrasound-incomplete stent apposition on stent failure.
    Catheter Cardiovasc Interv. 2022 Oct 27. doi: 10.1002/ccd.30424.
    PubMed     Abstract available


  259. NAIMI I, Morray B, Portman MA, Steinberg ZL, et al
    Use of the PK Papyrus covered coronary stent in the treatment of Kawasaki disease-associated giant coronary artery aneurysms.
    Catheter Cardiovasc Interv. 2022 Oct 26. doi: 10.1002/ccd.30458.
    PubMed     Abstract available


  260. KOSTANTINIS S, Simsek B, Karacsonyi J, Alaswad K, et al
    Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Oct 25. doi: 10.1002/ccd.30425.
    PubMed     Abstract available


  261. CORTESE B, Piraino D, Gentile D, Onea HL, et al
    Intravascular imaging for left main stem assessment: An update on the most recent clinical data.
    Catheter Cardiovasc Interv. 2022 Oct 23. doi: 10.1002/ccd.30440.
    PubMed     Abstract available


  262. ZHENG WC, Noaman S, Batchelor RJ, Hanson L, et al
    Evaluation of factors associated with selection for coronary angiography and in-hospital mortality among patients presenting with out-of-hospital cardiac arrest without ST-segment elevation.
    Catheter Cardiovasc Interv. 2022 Oct 23. doi: 10.1002/ccd.30442.
    PubMed     Abstract available


  263. GRINES CL, Tummala P
    Will the TRANSFORM II trial transform our management of small vessel coronary disease?
    Catheter Cardiovasc Interv. 2022 Oct 18. doi: 10.1002/ccd.30429.
    PubMed    


  264. ASLLANAJ B, Urzua A, Dota A, Levisman J, et al
    Non-surgical extirpation of a non-infectious expanding tricuspid valve mass by percutaneous aspiration thrombectomy.
    Catheter Cardiovasc Interv. 2022 Oct 18. doi: 10.1002/ccd.30428.
    PubMed     Abstract available


  265. SIDDIQI TJ, Khan MS, Karimi Galougahi K, Shlofmitz E, et al
    Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Oct 17. doi: 10.1002/ccd.30416.
    PubMed     Abstract available


  266. VERREAULT-JULIEN L, Shekiladze N, Wollmuth J, Rinfret S, et al
    Single-access for Impella-supported percutaneous coronary intervention using a sheathless technique with an 8 Fr guide.
    Catheter Cardiovasc Interv. 2022 Oct 13. doi: 10.1002/ccd.30427.
    PubMed     Abstract available


  267. MATHEWS SJ, Brown CL, Kolski BC, Marques VM, et al
    Initial experience with a continuous mechanical aspiration system for thrombus removal before percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30389.
    PubMed     Abstract available


  268. EARLE W, Abdallah G, Meagher S, Shen K, et al
    Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital-wide quality improvement initiative.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30412.
    PubMed     Abstract available


  269. KONG M, Ni M, Zhu X, Qian J, et al
    False lumen patency status and outcomes after endovascular repair of uncomplicated chronic type B dissection.
    Catheter Cardiovasc Interv. 2022;100:696-704.
    PubMed     Abstract available


  270. OSMAN M, Syed M, Simpson TF, Bhardwaj B, et al
    Incidence and outcomes of cardiogenic shock among women with spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2022;100:530-534.
    PubMed     Abstract available


  271. SHEKHAR S, Ajay A, Agrawal A, Kumar A, et al
    Radiation reduction in a modern catheterization laboratory: A single-center experience.
    Catheter Cardiovasc Interv. 2022;100:575-584.
    PubMed     Abstract available


  272. GRECO A, Sciahbasi A, Abizaid A, Mehran R, et al
    Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.
    Catheter Cardiovasc Interv. 2022;100:544-552.
    PubMed     Abstract available


  273. WANG HY, Mo R, Guan CD, Wang Y, et al
    Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2022;100:593-595.
    PubMed    


  274. CHAMBERS JW, Martinsen BJ, Sturm RC, Mandair D, et al
    Orbital atherectomy of calcified coronary ostial lesions.
    Catheter Cardiovasc Interv. 2022;100:553-559.
    PubMed     Abstract available


  275. QINTAR M, Wang DD, Lee J, Villablanca P, et al
    Transcatheter vacuum-assisted left-sided mass extraction with the AngioVac system.
    Catheter Cardiovasc Interv. 2022;100:628-635.
    PubMed     Abstract available


  276. WILGENHOF A, Vescovo GM, Bezzeccheri A, Scott B, et al
    Minimalistic hybrid approach for the percutaneous treatment of chronic coronary total occlusions: An in-depth analysis of the whole algorithm.
    Catheter Cardiovasc Interv. 2022;100:502-511.
    PubMed     Abstract available


  277. LEI J, Pu H, Wu Z, Huang Q, et al
    Local versus general anesthesia for endovascular aneurysm repair in ruptured abdominal aortic aneurysm: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022;100:679-686.
    PubMed     Abstract available


  278. PATEL M, Mujer M, John A, Darki A, et al
    VA-ECMO-assisted aspiration thrombectomy in a patient presenting with acute massive PE with absolute contraindications to thrombolytics.
    Catheter Cardiovasc Interv. 2022;100:705-709.
    PubMed     Abstract available


    September 2022
  279. MEGALY M, Buda K, Karacsonyi J, Kostantinis S, et al
    Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 28. doi: 10.1002/ccd.30403.
    PubMed     Abstract available


  280. BASHAR H, Matetic A, Curzen N, Mamas MA, et al
    Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 21. doi: 10.1002/ccd.30404.
    PubMed     Abstract available


  281. CARANDE EJ, Protty MB, Verhemel S, Hussein MH, et al
    Predictors of 30-day and 12-month mortality in left main stem percutaneous coronary intervention 2016-2020: A study from two UK centers.
    Catheter Cardiovasc Interv. 2022 Sep 14. doi: 10.1002/ccd.30400.
    PubMed     Abstract available


  282. AHLERS MJ, Srivastava PK, Basir MB, O'Neill WW, et al
    Characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock during COVID-19.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30390.
    PubMed     Abstract available


  283. SHAMKHANI W, Rashid M, Mamas M
    Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry.
    Catheter Cardiovasc Interv. 2022 Sep 2. doi: 10.1002/ccd.30366.
    PubMed     Abstract available


  284. GRINES CL, Dupont A
    Turndown for coronary artery bypass surgery: Never say never to revascularization.
    Catheter Cardiovasc Interv. 2022;100:367-368.
    PubMed     Abstract available


  285. MUSUMECI G, Civera S
    When not to treat could be the best option.
    Catheter Cardiovasc Interv. 2022;100:338-339.
    PubMed     Abstract available


  286. BUTMAN SM
    Variability in healthcare delivery: It is never a good thing.
    Catheter Cardiovasc Interv. 2022;100:317-318.
    PubMed     Abstract available


  287. WHITBECK MG, Chambers JW
    Treatment of cardiac device-related infective endocarditis utilizing the new T20 curve catheter and flow saver with the Inari mechanical aspiration system.
    Catheter Cardiovasc Interv. 2022;100:476-479.
    PubMed     Abstract available


  288. PATEL P, Sethi N, Patel GA, Kalisetti D, et al
    Evaluation of the incidence of radial artery occlusion using different introducer sheaths and hemostasis techniques.
    Catheter Cardiovasc Interv. 2022;100:387-391.
    PubMed     Abstract available


  289. HONDA Y, Yamawaki M, Mori S, Tsutsumi M, et al
    Predictive performance of J-Calc-CTO score for guidewire crossing through chronic total occlusion lesions within 30 minutes: J-CTO score modified by computed tomography coronary angiography.
    Catheter Cardiovasc Interv. 2022 Sep 1. doi: 10.1002/ccd.30384.
    PubMed     Abstract available


    August 2022
  290. SAGER R, Keller LS, Stehli J, Jakob P, et al
    Association of N-terminal pro-B-type natriuretic peptide with mortality in elderly (>/=80 years) patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30365.
    PubMed     Abstract available


  291. SAVAGE ML, Hay K, Murdoch DJ, Walters DL, et al
    Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30357.
    PubMed     Abstract available


  292. KOSTANTINIS S, Simsek B, Karacsonyi J, Davies RE, et al
    Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30354.
    PubMed     Abstract available


  293. VETROVEC GW
    Robotic coronary angiography: Advantages of stepping back.
    Catheter Cardiovasc Interv. 2022;100:214-215.
    PubMed    


  294. DI MARIO C, Kucukseymen S
    Second generation drug eluting stent: The longer, the better?
    Catheter Cardiovasc Interv. 2022;100:188-189.
    PubMed    


  295. MOUSLY H, Hajjari J, Chami T, Hammad T, et al
    Percutaneous mechanical thrombectomy and extracorporeal membranous oxygenation: A case series.
    Catheter Cardiovasc Interv. 2022;100:274-278.
    PubMed     Abstract available


  296. GAUTIER A, Hovasse T, Arroyo D, Unterseeh T, et al
    Safety and efficacy of 48 mm Xience Xpedition everolimus-eluting stent for the treatment of long coronary lesions.
    Catheter Cardiovasc Interv. 2022;100:179-187.
    PubMed     Abstract available


    July 2022
  297. FREUND A, van Royen N, Kern KB, Jobs A, et al
    Early coronary angiography in patients after out-of-hospital cardiac arrest without ST-segment elevation: Meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30355.
    PubMed     Abstract available


  298. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Antegrade dissection and re-entry versus parallel wiring in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30346.
    PubMed     Abstract available


  299. MUSTO C, Scappaticci M, Biondi-Zoccai G, De Felice F, et al
    Instantaneous wave-free ratio-guided revascularization of nonculprit lesions in STEMI patients with multivessel coronary disease: The WAVE registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30342.
    PubMed     Abstract available


  300. SIMSEK B, Gorgulu S, Kostantinis S, Karacsonyi J, et al
    Radial access for chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30347.
    PubMed     Abstract available


  301. BABAEV A, Halista M, Bakirova Z, Avtushka V, et al
    Directional versus orbital atherectomy of femoropopliteal artery lesions: Angiographic and intravascular ultrasound outcomes.
    Catheter Cardiovasc Interv. 2022 Jul 16. doi: 10.1002/ccd.30339.
    PubMed     Abstract available


  302. GALASSI AR, Vadala G, Testa G, Puglisi S, et al
    Dual guidewire balloon antegrade fenestration and re-entry technique for coronary chronic total occlusions percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2022 Jul 12. doi: 10.1002/ccd.30324.
    PubMed     Abstract available


  303. OKUYA Y, Gohil K, Moussa ID
    Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: Network meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jul 5. doi: 10.1002/ccd.30304.
    PubMed     Abstract available


  304. SHELDON M, Blankenship JC
    STEMI in nonagenarians: Never too old.
    Catheter Cardiovasc Interv. 2022;100:17-18.
    PubMed    


  305. ASHLEY KE, Hillegass WB
    Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;100:83-84.
    PubMed    


  306. DI SERAFINO L, Esposito G
    May FFR-guided PCI save lives?: Commentary on: "Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry".
    Catheter Cardiovasc Interv. 2022;100:49-50.
    PubMed    


  307. KALYANASUNDARAM A, Seth A
    Retrograde CTO PCI-the final frontier-challenges and outcomes.
    Catheter Cardiovasc Interv. 2022;100:28-29.
    PubMed    


  308. GRINES CL, Marshall JJ
    Directional coronary atherectomy revisited.
    Catheter Cardiovasc Interv. 2022;100:59-60.
    PubMed    


  309. ADJEDJ J, Morelle JF, Saint Etienne C, Fichaux O, et al
    Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry.
    Catheter Cardiovasc Interv. 2022;100:40-48.
    PubMed     Abstract available


  310. LIANG B, Gu N
    High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials.
    Catheter Cardiovasc Interv. 2022;100:61-71.
    PubMed     Abstract available


  311. FARAG M, Al-Atta A, Abdalazeem I, Salim T, et al
    Clinical outcomes of percutaneous coronary intervention in high-risk patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2022 Jul 1. doi: 10.1002/ccd.30318.
    PubMed     Abstract available


    June 2022
  312. RASHID M, Kinnaird T, Ludman P, Keeble TR, et al
    Variation in practice for out-of-hospital cardiac arrest treated with percutaneous coronary intervention in England and Wales.
    Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30316.
    PubMed     Abstract available


  313. PAVANI M, Cerrato E, Franze A, Colombo F, et al
    Grade 3 coronary artery perforations in chronic total occlusion-percutaneous coronary intervention: Mechanisms, locations, and outcomes from the G3CAP Registry.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30293.
    PubMed     Abstract available


  314. SIMSEK B, Brilakis ES
    Why double-kissing crush should be preferred over culotte for two-stent bifurcation stenting.
    Catheter Cardiovasc Interv. 2022;99:2006-2007.
    PubMed    


  315. SETO AH
    Closing the loop in cath lab communication: Avoiding the tower of babble.
    Catheter Cardiovasc Interv. 2022;99:1963-1964.
    PubMed    


  316. KARACSONYI J, Brilakis ES, Chandwaney RH
    Guide-Extension Carlino: A novel technique for crossing a microcatheter uncrossable proximal cap during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2022;99:2038-2042.
    PubMed     Abstract available


  317. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
    Catheter Cardiovasc Interv. 2022;99:1965-1975.
    PubMed     Abstract available


  318. KOBAYASHI N, Ito Y, Kishi K, Muramatsu T, et al
    Procedural results and in-hospital outcomes of percutaneous coronary intervention for chronic total occlusion in patients with reduced left ventricular ejection fraction: Sub-analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2022 Jun 1. doi: 10.1002/ccd.30231.
    PubMed     Abstract available


    May 2022
  319. JOSEPH T, VanOosterhout S, Negash A, VanLoo L, et al
    Robotically performed diagnostic coronary angiography.
    Catheter Cardiovasc Interv. 2022 May 27. doi: 10.1002/ccd.30250.
    PubMed     Abstract available


  320. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30228.
    PubMed     Abstract available


  321. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    Overview of in-hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy.
    Catheter Cardiovasc Interv. 2022 May 20. doi: 10.1002/ccd.30233.
    PubMed     Abstract available


  322. ISMAYL M, Machanahalli Balakrishna A, Walters RW, Pajjuru VS, et al
    In-hospital mortality and readmission after ST-elevation myocardial infarction in nonagenarians: A nationwide analysis from the United States.
    Catheter Cardiovasc Interv. 2022 May 14. doi: 10.1002/ccd.30227.
    PubMed     Abstract available


  323. VAN HATTEM VAE, Otterspoor LC, Lipsic E, Vlaar PJJ, et al
    Right ventricular hematoma: A rare but potentially fatal complication of percutaneous coronary artery intervention.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30226.
    PubMed     Abstract available


  324. ONO M, Onuma Y, Kawashima H, Hara H, et al
    Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30217.
    PubMed     Abstract available


  325. JOVIN IS, Warsavage TJ, Plomondon ME, Grunwald GK, et al
    Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30218.
    PubMed     Abstract available


  326. MA W, Wang Q, Wang B, Wang C, et al
    Novel predictors of stent under-expansion regarding calcified coronary lesions assessed by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1473-1481.
    PubMed     Abstract available


  327. WANG M, Liu H, Xu B, Bian X, et al
    Protective ballooning technique for prevention of side branch occlusion in coronary nonleft main true bifurcation lesions: A single-center study.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1418-1423.
    PubMed     Abstract available


  328. HE J, Zhang D, Zhang R, Wang H, et al
    Validation of the V-RESOLVE (Visual Estimation for Risk prEdiction of Side Branch OccLusion in Coronary Bifurcation interVEntion) score system in unprotected left main bifurcation.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1465-1472.
    PubMed     Abstract available


  329. GUAN C, Geng L, Zhang R, You J, et al
    Long-term prognostic value of dynamic function assessment of intermediate coronary lesion with computational physiology.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1386-1394.
    PubMed     Abstract available


  330. LEE A, Kimmelstiel C
    Stretching and cutting after drilling. Vessel preparation following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022;99:1750-1751.
    PubMed    


  331. PATEL N, Bandyopadhyay D, Agarwal G, Chakraborty S, et al
    Outcomes of rotational atherectomy followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified coronary lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1741-1749.
    PubMed     Abstract available


  332. BEOHAR N, Stone GW, Martinsen BJ, Parise H, et al
    Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real-world comparative analysis.
    Catheter Cardiovasc Interv. 2022;99:1752-1757.
    PubMed     Abstract available


  333. DALEN M, Settergren M, Kastengren M, Ullstrom P, et al
    Percutaneous decannulation of extracorporeal membrane oxygenation using a plug-based closure device.
    Catheter Cardiovasc Interv. 2022;99:1945-1952.
    PubMed     Abstract available


    April 2022
  334. SALEM H, Mintz GS, Matsumura M, Zhang M, et al
    Reasons for lesion uncrossability as assessed by intravascular ultrasound.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30202.
    PubMed     Abstract available


  335. MOTIWALA A, Jneid H
    Reflections on the association of thrombocytopenia with adverse outcomes after PCI.
    Catheter Cardiovasc Interv. 2022;99:1498-1499.
    PubMed    


  336. FABRIS E, Menzio S, Gregorio C, Pezzato A, et al
    Effect of prehospital treatment in STEMI patients undergoing primary PCI.
    Catheter Cardiovasc Interv. 2022;99:1500-1508.
    PubMed     Abstract available


  337. GROOT JEBBINK E, van Wijck I, Holewijn S, Iida O, et al
    Individual patient data meta-analysis of patients treated with a heparin-bonded Viabahn in the femoropopliteal artery for chronic limb-threatening ischemia.
    Catheter Cardiovasc Interv. 2022;99:1714-1722.
    PubMed     Abstract available


  338. RIVERO F, Marco V, Biccire FG, Budassi S, et al
    The double injection technique to improve visualization of severe coronary lesions with optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;99:1511-1517.
    PubMed     Abstract available


  339. SONCK J, Mizukami T, Johnson NP, Nagumo S, et al
    Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks.
    Catheter Cardiovasc Interv. 2022;99:1518-1525.
    PubMed     Abstract available


  340. KHOKHAR AA, Zelias A, Zlahoda-Huzior A, Dudek D, et al
    Complication during robotic-PCI: Iatrogenic guiding catheter dissection.
    Catheter Cardiovasc Interv. 2022;99:1526-1528.
    PubMed     Abstract available


    March 2022
  341. SIMSEK B, Kostantinis S, Karacsonyi J, Hall A, et al
    International percutaneous coronary intervention complication survey.
    Catheter Cardiovasc Interv. 2022 Mar 29. doi: 10.1002/ccd.30173.
    PubMed     Abstract available


  342. SUMMERS MR, Lavigne PM, Mahoney PD
    Completion peripheral angiography in single-access, Impella-assisted, high-risk PCI: Using a buddy microcatheter sheath after MANTA closure for imaging and potential bailout.
    Catheter Cardiovasc Interv. 2022 Mar 29. doi: 10.1002/ccd.30145.
    PubMed     Abstract available


  343. JANUSZEK R, Siudak Z, Malinowski KP, Wanha W, et al
    Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes: Analysis based on a large national registry.
    Catheter Cardiovasc Interv. 2022 Mar 22. doi: 10.1002/ccd.30155.
    PubMed     Abstract available


  344. SANZ-SANCHEZ J, Mashayekhi K, Agostoni P, Egred M, et al
    Device entrapment during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30160.
    PubMed     Abstract available


  345. VALLURUPALLI S, Hess E, Plomondon ME, Park K, et al
    Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program.
    Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30142.
    PubMed     Abstract available


  346. TARANTINI G, Cardaioli F
    Bioresorbable scaffolds: zebras are not striped horses.
    Catheter Cardiovasc Interv. 2022;99:1084-1085.
    PubMed    


  347. WINSCOTT JG, Hillegass WB
    Successfully treating the common femoral artery "no go zone" with directional atherectomy plus antirestenotic therapy (DAART).
    Catheter Cardiovasc Interv. 2022;99:1317-1318.
    PubMed    


  348. PATEL NJ, Heuser RR
    Physiologic liquid plumber: A novel treatment to facilitate crossing of chronic total occlusions.
    Catheter Cardiovasc Interv. 2022;99:1074.
    PubMed    


  349. DROSOU ME, Gray WA
    Clipping costs.
    Catheter Cardiovasc Interv. 2022;99:1257-1258.
    PubMed    


  350. GRINES CL, Marshall JJ
    Step back to see the complete picture: Complete versus incomplete revascularization of multivessel coronary disease.
    Catheter Cardiovasc Interv. 2022;99:968-969.
    PubMed    


  351. KUMAR A, Huded CP, Kassis N, Martin J, et al
    Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
    Catheter Cardiovasc Interv. 2022;99:1363-1365.
    PubMed    


  352. DANGAS G, Garg A
    Double kissing crush stenting: No pain, no gain?
    Catheter Cardiovasc Interv. 2022;99:1045-1046.
    PubMed    


  353. SIMSEK B, Kostantinis S, Karacsonyi J, Vemmou E, et al
    Challenges and outcomes of the double kissing crush stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;99:1038-1044.
    PubMed     Abstract available


  354. BISCAGLIA S, Erriquez A, Serenelli M, D'Ascenzo F, et al
    Complete versus culprit-only strategy in older MI patients with multivessel disease.
    Catheter Cardiovasc Interv. 2022;99:970-978.
    PubMed     Abstract available


  355. MURASATO Y, Watanabe Y, Yamawaki M, Kinoshita Y, et al
    Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
    Catheter Cardiovasc Interv. 2022;99:1047-1058.
    PubMed     Abstract available


  356. KARIM AM, Li J, Panhwar MS, Arshad S, et al
    Impact of malnutrition and frailty on mortality and major amputation in patients with CLTI.
    Catheter Cardiovasc Interv. 2022;99:1300-1309.
    PubMed     Abstract available


  357. TOMA C, Bunte MC, Cho KH, Jaber WA, et al
    Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: Interim results of the FLASH registry.
    Catheter Cardiovasc Interv. 2022;99:1345-1355.
    PubMed     Abstract available


  358. TAKAHASHI T, Nishi T, Zimmermann FM, Granada JF, et al
    Clinical validation of a novel simplified offline tool for SYNTAX score calculation.
    Catheter Cardiovasc Interv. 2022;99:1366-1368.
    PubMed    


  359. GRAHAM JJ, Bagai A, Wijeysundera H, Weisz G, et al
    Collagenase to facilitate guidewire crossing in chronic total occlusion PCI-The Total Occlusion Study in Coronary Arteries-5 (TOSCA-5) trial.
    Catheter Cardiovasc Interv. 2022;99:1065-1073.
    PubMed     Abstract available


  360. SINGH N, Ding L, Magee GA, Shavelle DM, et al
    Contemporary treatment of below-the-knee peripheral arterial disease in patients with chronic limb threatening ischemia: Observations from the Vascular Quality Initiative.
    Catheter Cardiovasc Interv. 2022;99:1289-1299.
    PubMed     Abstract available


  361. NAN TIE E, Fernando H, Nehme Z, Dinh D, et al
    Sex differences in prehospital analgesia in patients presenting with acute coronary syndromes and their association with clinical outcomes.
    Catheter Cardiovasc Interv. 2022;99:989-995.
    PubMed     Abstract available


  362. ULLAH W, Zghouzi M, Sattar Z, Ahmad B, et al
    Safety and efficacy of drug-coated balloon for peripheral artery revascularization-A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1319-1326.
    PubMed     Abstract available


  363. HANSEN KN, Maeng M, Raungaard B, Engstrom T, et al
    Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial.
    Catheter Cardiovasc Interv. 2022;99:1095-1103.
    PubMed     Abstract available


  364. PARK JH, Rha SW
    Early-onset persistent type IIIb endoleak following incraft stent graft implantation in an abdominal aortic aneurysm patient.
    Catheter Cardiovasc Interv. 2022;99:1358-1362.
    PubMed     Abstract available


  365. BARKHOLT TO, Neghabat O, Holck EN, Andreasen LN, et al
    Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
    Catheter Cardiovasc Interv. 2022;99:1075-1083.
    PubMed     Abstract available


  366. WILLIAMS T, Mittal A, Karageorgiev D, Iniguez Romo A, et al
    Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry.
    Catheter Cardiovasc Interv. 2022;99:961-967.
    PubMed     Abstract available


  367. CIOPPA A, Franzese M, Gerardi D, Pucciarelli A, et al
    Three-year outcome of directional atherectomy and drug coated balloon for the treatment of common femoral artery steno-occlusive lesions.
    Catheter Cardiovasc Interv. 2022;99:1310-1316.
    PubMed     Abstract available


  368. PRASAD A, Amin AP, Ryan MP, Gunnarsson C, et al
    Use of iso-osmolar contrast media during endovascular revascularization is associated with a lower incidence of major adverse renal, cardiac, or limb events.
    Catheter Cardiovasc Interv. 2022;99:1335-1342.
    PubMed     Abstract available


    February 2022
  369. ARCHILLETTI F, Giuliani L, Dangas GD, Ricci F, et al
    Timing of mechanical circulatory support during primary angioplasty in acute myocardial infarction and cardiogenic shock: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Feb 19. doi: 10.1002/ccd.30137.
    PubMed     Abstract available


  370. HANNA EB, Rossen J, Eustes AS, Dayal S, et al
    Heavy lone coronary artery thrombosis treated by stent retriever, in the setting of COVID-19 infection.
    Catheter Cardiovasc Interv. 2022;99:457-461.
    PubMed     Abstract available


  371. KITE TA, Ladwiniec A, Owens CG, Chase A, et al
    Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.
    Catheter Cardiovasc Interv. 2022;99:305-313.
    PubMed     Abstract available


  372. ALASNAG M
    Sound and light editorial: The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2022;99:674-675.
    PubMed    


  373. TEHRANI DM, Seto AH
    Clinical risk overlaps both bare metal and drug-eluting stents.
    Catheter Cardiovasc Interv. 2022;99:552-553.
    PubMed    


  374. VARBELLA F, Cerrato E, Rolfo C, Quadri G, et al
    Characteristics and outcomes of elderly patients undergoing carotid stenting: Experience of a high-volume interventional cardiology center.
    Catheter Cardiovasc Interv. 2022;99:853-859.
    PubMed     Abstract available


  375. TARANTINI G, Cardaioli F
    Coronary complete revascularization strategy: A puzzle still hard to complete.
    Catheter Cardiovasc Interv. 2022;99:639-640.
    PubMed    


  376. GOLDSTEIN JA, Mehta NK
    Extent of coronary atherosclerosis and ischemic myocardium foment sudden cardiac death.
    Catheter Cardiovasc Interv. 2022;99:812-813.
    PubMed    


  377. LOW RJB, Khoo DZL, Ong PJL
    Case report: A novel application of the MicroVascular Plug (MVP) in treating distal coronary perforation.
    Catheter Cardiovasc Interv. 2022;99:502-507.
    PubMed     Abstract available


  378. HIDALGO F, Gonzalez-Manzanares R, Ojeda S, Benito-Gonzalez T, et al
    Instantaneous wave-free ratio for guiding treatment of nonculprit lesions in patients with acute coronary syndrome: A retrospective study.
    Catheter Cardiovasc Interv. 2022;99:489-496.
    PubMed     Abstract available


  379. XU R, Shi Y, Chang S, Qin Q, et al
    Outcomes of contemporary versus conventional reverse controlled and antegrade and retrograde subintimal tracking in chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2022;99:226-233.
    PubMed     Abstract available


  380. LEE K, Lee PH, Lee SW, Kwon O, et al
    Primary versus rescue retrograde approach for chronic total coronary occlusion.
    Catheter Cardiovasc Interv. 2022;99:219-225.
    PubMed     Abstract available


  381. PACCHIONI A, Mugnolo A, Sanz Sanchez J, Sgueglia GA, et al
    Radial artery occlusion after conventional and distal radial access: Impact of preserved flow and time-to-hemostasis in a propensity-score matching analysis of 1163 patients.
    Catheter Cardiovasc Interv. 2022;99:827-835.
    PubMed     Abstract available


  382. BOCCHINO PP, Franchin L, Angelini F, D'Ascenzo F, et al
    Outcomes during the first year following spontaneous coronary artery dissection: A systematic timeframe pooled analysis.
    Catheter Cardiovasc Interv. 2022;99:472-479.
    PubMed     Abstract available


  383. KANDZARI DE, Alaswad K, Jaffer FA, Brilakis E, et al
    Safety and efficacy of dedicated guidewire, microcatheter, and guide catheter extension technologies for chronic total coronary occlusion revascularization: Primary results of the Teleflex Chronic Total Occlusion Study.
    Catheter Cardiovasc Interv. 2022;99:263-270.
    PubMed     Abstract available


  384. COUGHLAN JJ, Aytekin A, Koch T, Wiebe J, et al
    Long-term clinical outcomes after drug eluting stent implantation with and without stent overlap.
    Catheter Cardiovasc Interv. 2022;99:541-551.
    PubMed     Abstract available


  385. KANDZARI DE, Kirtane AJ, Mehran R, Price MJ, et al
    Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
    Catheter Cardiovasc Interv. 2022;99:583-592.
    PubMed     Abstract available


  386. WIEBE J, Hofmann FJ, West N, Baumbach A, et al
    Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium.
    Catheter Cardiovasc Interv. 2022;99:533-540.
    PubMed     Abstract available


  387. NOGIC J, Nerlekar N, Soon K, Freeman M, et al
    Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry.
    Catheter Cardiovasc Interv. 2022;99:554-562.
    PubMed     Abstract available


  388. ERBEN Y, Meschia JF, Heck DV, Shawl FA, et al
    Safety of the transradial approach to carotid stenting.
    Catheter Cardiovasc Interv. 2022;99:814-821.
    PubMed     Abstract available


  389. EBERLI FR, Stoll HP, Urban P, Morice MC, et al
    Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.
    Catheter Cardiovasc Interv. 2022;99:593-600.
    PubMed     Abstract available


  390. HUSSAIN Y, Gaston S, Kluger J, Shah T, et al
    Long term outcomes of ultrathin versus standard thickness second-generation drug eluting stents: Meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2022;99:563-574.
    PubMed     Abstract available


  391. HAKEEM A, Hou L, Shah K, Agarwal SK, et al
    Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry.
    Catheter Cardiovasc Interv. 2022;99:714-722.
    PubMed     Abstract available


  392. NOIRCLERC N, Marliere S, Bakhti A, Mangin L, et al
    Impact of a micro-net mesh technology covering stent on coronary microvascular dysfunction in patients with high thrombus burden.
    Catheter Cardiovasc Interv. 2022;99:397-404.
    PubMed     Abstract available


  393. SCARSINI R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, et al
    Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI.
    Catheter Cardiovasc Interv. 2022;99:329-339.
    PubMed     Abstract available


  394. KARMPALIOTIS D, Stoler R, Walsh S, El-Jack S, et al
    Safety and efficacy of Everolimus-Eluting bioabsorbable Polymer-Coated stent in patients with long coronary lesions: The EVOLVE 48 study.
    Catheter Cardiovasc Interv. 2022;99:373-380.
    PubMed     Abstract available


  395. ZAFIROVSKA B, Jovkovski A, Vasilev I, Taravari H, et al
    Ipsilateral transulnar artery approach catheterizations after failure of the radial approach-Are two sheaths in the same arm safe?
    Catheter Cardiovasc Interv. 2022;99:411-417.
    PubMed     Abstract available


  396. OSMAN M, Ghaffar YA, Osman K, Kheiri B, et al
    Gender-based outcomes of coronary bifurcation stenting: A report from the National Readmission Database.
    Catheter Cardiovasc Interv. 2022;99:433-439.
    PubMed     Abstract available


  397. VAN HEMERT ND, Rozemeijer R, Voskuil M, Stein M, et al
    Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.
    Catheter Cardiovasc Interv. 2022;99:366-372.
    PubMed     Abstract available


  398. IQBAL MB, Moore PT, Nadra IJ, Robinson SD, et al
    Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British Columbia Cardiac Registry.
    Catheter Cardiovasc Interv. 2022;99:627-638.
    PubMed     Abstract available


  399. ANCHAN R, Venturini J, Larsen P, Lee L, et al
    Safe and rapid radial hemostasis achieved using a novel topical hemostatic patch: Results of a first-in-human pilot study using hydrophobically modified polysaccharide-chitosan.
    Catheter Cardiovasc Interv. 2022;99:786-794.
    PubMed     Abstract available


  400. G TOTH G, Ono M, Buschmann E, Wu X, et al
    Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
    Catheter Cardiovasc Interv. 2022;99:424-432.
    PubMed     Abstract available


  401. SAITO Y, Wijns W, Baumbach A, Xu B, et al
    Differential impact of abluminal groove-filled biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent on and off dual antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;99:357-365.
    PubMed     Abstract available


    January 2022
  402. TORABI AJ, Mshelbwala FS, Hugenberg D, Kovacs RJ, et al
    Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30108.
    PubMed     Abstract available


  403. CHEN S, Li J, Qiu M, Ma S, et al
    Predictors and long-term outcomes of in-hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30089.
    PubMed     Abstract available


  404. LI J, Liu X, Ma S, Na K, et al
    Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30099.
    PubMed     Abstract available


  405. HONG XL, Li Y, Fu GS, Zhang WB, et al
    Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30095.
    PubMed     Abstract available


  406. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30097.
    PubMed     Abstract available


  407. SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
    Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
    PubMed     Abstract available


  408. LI Y, Li J, Qiu M, Ma S, et al
    Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30077.
    PubMed     Abstract available


  409. LI W, Takahashi T, Rios SA, Latib A, et al
    Diagnostic performance and prognostic impact of coronary angiography-based Index of Microcirculatory Resistance assessment: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30076.
    PubMed     Abstract available


  410. MANGIACAPRA F, Paolucci L, Viscusi MM, Mangiacapra R, et al
    Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30071.
    PubMed     Abstract available


  411. SIMSEK B, Brilakis ES
    Chronic total occlusion percutaneous coronary intervention in prior coronary artery bypass graft surgery patients: Caveat Emptor!
    Catheter Cardiovasc Interv. 2022;99:85-87.
    PubMed    


  412. LI J, Arora S, Ikeoka K, Smith J, et al
    The utility of geriatric nutritional risk index to predict outcomes in chronic limb-threatening ischemia.
    Catheter Cardiovasc Interv. 2022;99:121-133.
    PubMed     Abstract available


  413. IMPROTA R, Scarparo P, Wilschut J, Wolff Q, et al
    Elastic stent recoil in coronary total occlusions: Comparison of durable-polymer zotarolimus eluting stent and ultrathin strut bioabsorbable-polymer sirolimus eluting stent.
    Catheter Cardiovasc Interv. 2022;99:88-97.
    PubMed     Abstract available


  414. WANG HY, Mo R, Guan CD, Wang Y, et al
    Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2022;99:98-113.
    PubMed     Abstract available


  415. VEMMOU E, Nikolakopoulos I, Xenogiannis I, Karacsonyi J, et al
    Learning and innovation among interventional cardiologists: Insights from an international survey.
    Catheter Cardiovasc Interv. 2022;99:11-16.
    PubMed     Abstract available


  416. NAVARESE EP, Kandzari DE
    REPLY: ITT (intrepret and test to effectively treat) approach for no-reflow.
    Catheter Cardiovasc Interv. 2022;99:E44-E45.
    PubMed    


  417. MOVAHED MR
    Distal administration of very high doses of adenosine using over-the-wire balloon or export catheter should be the first choice for treatment of patients with resistant no-reflow.
    Catheter Cardiovasc Interv. 2022;99:E43.
    PubMed    


    December 2021
  418. DEMIR OM, Little CD, Jabbour R, Rahman H, et al
    Impact of COVID-19 pandemic on the management of nonculprit lesions in patients presenting with ST-elevation myocardial infarction: Outcomes from the pan-London heart attack centers.
    Catheter Cardiovasc Interv. 2021 Dec 30. doi: 10.1002/ccd.30056.
    PubMed     Abstract available


  419. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
    Catheter Cardiovasc Interv. 2021 Dec 28. doi: 10.1002/ccd.30049.
    PubMed     Abstract available


  420. GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
    The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
    PubMed     Abstract available


  421. HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
    Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
    PubMed     Abstract available


  422. KORNOWSKI R
    Left main coronary revascularization strategies in the COVID-19 era.
    Catheter Cardiovasc Interv. 2021;98:1262-1263.
    PubMed    


  423. VETROVEC GW
    Surgical turndowns are not no option patients.
    Catheter Cardiovasc Interv. 2021;98:1230-1231.
    PubMed    


  424. TOPAZ O
    Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations.
    Catheter Cardiovasc Interv. 2021;98:1250-1251.
    PubMed    


  425. KUMAR A, Jneid H
    Predicting mortality after percutaneous coronary intervention: The need for improved risk models.
    Catheter Cardiovasc Interv. 2021;98:1298-1299.
    PubMed    


  426. SHUNK KA
    The CathPCI Registry (still) welcomes ambulatory surgical center participation.
    Catheter Cardiovasc Interv. 2021;98:1415.
    PubMed    


  427. RAO S, Karuppasamy K, Radhakrishnan K, Fagan TE, et al
    Restriction of congenital portosystemic shunt using the modified microvascular plug.
    Catheter Cardiovasc Interv. 2021;98:1358-1362.
    PubMed     Abstract available


  428. KLEIN LW, Tamis-Holland J, Kirtane AJ, Anderson HV, et al
    The appropriate use criteria: Improvements for its integration into real world clinical practice.
    Catheter Cardiovasc Interv. 2021;98:1349-1357.
    PubMed     Abstract available


  429. CHICHAREON P, van Klaveren D, Modolo R, Kogame N, et al
    Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score.
    Catheter Cardiovasc Interv. 2021;98:1287-1297.
    PubMed     Abstract available


  430. VERDOIA M, Rolla R, Pergolini P, Gioscia R, et al
    Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor.
    Catheter Cardiovasc Interv. 2021;98:1309-1316.
    PubMed     Abstract available


  431. ABHYANKAR A, Abizaid A, Chamie D, Patel G, et al
    Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:1335-1342.
    PubMed     Abstract available


  432. OJEDA S, Azzalini L, Suarez de Lezo J, Johal GS, et al
    Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1241-1249.
    PubMed     Abstract available


  433. KOUTOUZIS M, Liontou C, Xenogiannis I, Tajti P, et al
    Same day discharge after chronic total occlusion interventions: A single center experience.
    Catheter Cardiovasc Interv. 2021;98:1232-1239.
    PubMed     Abstract available


    November 2021
  434. BHARDWAJ B, Gunzburger E, Valle JA, Grunwald GK, et al
    Radial versus femoral access for left main percutaneous coronary intervention: An analysis from the Veterans Affairs Clinical, Reporting, and Tracking Program.
    Catheter Cardiovasc Interv. 2021 Nov 30. doi: 10.1002/ccd.30024.
    PubMed     Abstract available


  435. SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
    Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
    PubMed     Abstract available


  436. AKL E, Pinilla-Echeverri N, Garcia-Garcia HM, Mehta SR, et al
    First in-human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imaging.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30001.
    PubMed     Abstract available


  437. KUFNER S, Rai H, Wiebe J, Altevogt F, et al
    A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
    PubMed     Abstract available


  438. VALLURUPALLI S, Salehi N, Agarwal S, Hasan R, et al
    Exhaustion of coronary vasodilatory reserve in the resting state: Clinical characteristics and long-term outcomes after intervention.
    Catheter Cardiovasc Interv. 2021;98:1021-1026.
    PubMed     Abstract available


  439. DAVIES RE, Rier JD, McEntegart M, Riley RF, et al
    Subintimal tracking and reentry as a tool in CTO-PCI: Past, present, and future.
    Catheter Cardiovasc Interv. 2021;98:1144-1151.
    PubMed    


  440. MEHTA S, Grines CL, Botelho R, Fernandez F, et al
    STEMI telemedicine for 100 million lives.
    Catheter Cardiovasc Interv. 2021;98:1066-1071.
    PubMed     Abstract available


  441. PIAYDA K, Grunwald I, Sievert K, Bertog S, et al
    Acute stroke intervention for acute embolic procedural strokes performed by cardiologists.
    Catheter Cardiovasc Interv. 2021;98:E963-E967.
    PubMed     Abstract available


  442. MARMAGKIOLIS K, Caballero JA, Cilingiroglu M, Iliescu C, et al
    Single-access dual-injection technique (SADIT) for high-risk PCI with Impella CP.
    Catheter Cardiovasc Interv. 2021;98:1138-1140.
    PubMed     Abstract available


  443. ROY S, Choxi R, Wasilewski M, Jovin IS, et al
    Novel oral anticoagulants in the treatment of radial artery occlusion.
    Catheter Cardiovasc Interv. 2021;98:1133-1137.
    PubMed     Abstract available


  444. CERRATO E, Belliggiano D, Quadri G, Erriquez A, et al
    Anatomical and functional healing after resorbable magnesium scaffold implantation in human coronary vessels: A combined optical coherence tomography and quantitative flow ratio analysis.
    Catheter Cardiovasc Interv. 2021;98:1038-1046.
    PubMed     Abstract available


  445. NIKOLAKOPOULOS I, Vemmou E, Xenogiannis I, Karacsonyi J, et al
    Radial versus femoral access in patients with coronary artery bypass surgery: Frequentist and Bayesian meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 14. doi: 10.1002/ccd.30010.
    PubMed     Abstract available


  446. TAMIS-HOLLAND JE, Puvanalingam A, Cigarroa J
    Physician practice patterns in managing severe multivessel disease in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Nov 13. doi: 10.1002/ccd.30004.
    PubMed    


  447. KIRRESH A, Candilio L, Stone GW
    Intralesional delivery of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction: Review and recommendations.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30008.
    PubMed     Abstract available


  448. LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
    Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
    PubMed     Abstract available


  449. KALETA FP, Gilchrist IC
    PRECISE-DAPT: A tool to measure if Afib patients may risk being stretched too thin.
    Catheter Cardiovasc Interv. 2021;98:846-847.
    PubMed    


  450. TOELG R, Slagboom T, Waltenberger J, Lefevre T, et al
    Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent.
    Catheter Cardiovasc Interv. 2021;98:848-856.
    PubMed     Abstract available


  451. FUJIHARA M, Takahara M, Yamaoka T, Iida O, et al
    Clinical outcomes of endovascular procedure using VIABAHN(R) VBX covered stent in complex aortoiliac artery disease: Result from AVOCADO study.
    Catheter Cardiovasc Interv. 2021;98:928-937.
    PubMed     Abstract available


  452. NOGUCHI M, Dohi T, Okazaki S, Matsumura M, et al
    Comparison of 6-month vascular healing response after bioresorbable polymer versus durable polymer drug-eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:E677-E686.
    PubMed     Abstract available


  453. ZANCA F, Dabin J, Collard C, Alexandre N, et al
    Evaluation of a suspended radiation protection system to reduce operator exposure in cardiology interventional procedures.
    Catheter Cardiovasc Interv. 2021;98:E687-E694.
    PubMed     Abstract available


  454. FAGEL ND, Amoroso G, Rabbering T, Gescher F, et al
    One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis.
    Catheter Cardiovasc Interv. 2021;98:E661-E667.
    PubMed     Abstract available


  455. KHAN AA, Murtaza G, Khalid MF, White CJ, et al
    Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:884-892.
    PubMed     Abstract available


  456. HERNANDEZ-ENRIQUEZ M, Belle L, Madiot H, Pansieri M, et al
    Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry.
    Catheter Cardiovasc Interv. 2021;98:874-881.
    PubMed     Abstract available


  457. SALINAS P, Sanchez-Casanueva RM, Gonzalo N, A Gil J, et al
    Dose-reducing fluoroscopic system decreases patient but not occupational radiation exposure in chronic total occlusion intervention.
    Catheter Cardiovasc Interv. 2021;98:895-902.
    PubMed     Abstract available


  458. D'ASCENZO F, Saglietto A, Ramakrishna H, Andreis A, et al
    Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry.
    Catheter Cardiovasc Interv. 2021;98:864-871.
    PubMed     Abstract available


  459. WIEBE J, Rai H, Kuna C, Cassese S, et al
    Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
    Catheter Cardiovasc Interv. 2021;98:857-862.
    PubMed     Abstract available


    October 2021
  460. SATTAR Y, Abdul Razzack A, Kompella R, Alhajri N, et al
    Outcomes of intravascular ultrasound versus optical coherence tomography guided percutaneous coronary angiography: A meta regression-based analysis.
    Catheter Cardiovasc Interv. 2021 Oct 20. doi: 10.1002/ccd.29976.
    PubMed     Abstract available


  461. DAI N, Zhang R, Hu N, Guan C, et al
    Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Oct 15. doi: 10.1002/ccd.29983.
    PubMed     Abstract available


  462. HAWAMDEH H, Moliterno DJ
    Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;98:689-690.
    PubMed     Abstract available


  463. KERN MJ
    Does rotoblation or cutting balloon before provisional stenting of calcified side branches make any difference? Comparing results by OCT and FFR.
    Catheter Cardiovasc Interv. 2021;98:669-670.
    PubMed    


  464. KOH JS, Gogas BD, Kumar S, Benham JJ, et al
    Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;98:723-732.
    PubMed     Abstract available


  465. ZGHOUZI M, Moussa Pacha H, Ullah W, Sattar Y, et al
    In-hospital outcomes of endovascular versus surgical revascularization for chronic total occlusion in peripheral artery disease.
    Catheter Cardiovasc Interv. 2021;98:E586-E593.
    PubMed     Abstract available


  466. BOEDER NF, Kastner J, Mehilli J, Munzel T, et al
    Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy.
    Catheter Cardiovasc Interv. 2021;98:E555-E563.
    PubMed     Abstract available


  467. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    PubMed     Abstract available


  468. TROBS M, Achenbach S, Nef HM, Gori T, et al
    Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:E564-E570.
    PubMed     Abstract available


  469. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    PubMed     Abstract available


  470. ONO M, Kawashima H, Hara H, Gamal A, et al
    External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2021;98:E513-E522.
    PubMed     Abstract available


  471. YELAVARTHY P, Seth M, Pielsticker E, Grines CL, et al
    The DISCO study-Does Interventionalists' Sex impact Coronary Outcomes?
    Catheter Cardiovasc Interv. 2021;98:E531-E539.
    PubMed     Abstract available


  472. MEMON S, George JC, Kalra S, Janzer S, et al
    Antegrade and retrograde in-stent tibial artery chronic total occlusion recanalization with double kiss crush (DK crush) stenting of previous stent.
    Catheter Cardiovasc Interv. 2021;98:743-747.
    PubMed     Abstract available


  473. RAMASAMY A, Bajaj R, Jones DA, Amersey R, et al
    Iatrogenic catheter-induced ostial coronary artery dissections: Prevalence, management, and mortality from a cohort of 55,968 patients over 10 years.
    Catheter Cardiovasc Interv. 2021;98:649-655.
    PubMed     Abstract available


  474. MIDULLA M, Chevallier O, Comby PO, Giordano G, et al
    Endovascular management of the deep venous thrombosis: A new challenging role for the endovascular specialist in 2020.
    Catheter Cardiovasc Interv. 2021;98:748-755.
    PubMed     Abstract available


  475. KERKMEIJER LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, et al
    Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
    Catheter Cardiovasc Interv. 2021;98:713-720.
    PubMed     Abstract available


  476. SAPONTIS J, Hirai T, Patterson C, Gans B, et al
    Intermediate procedural and health status outcomes and the clinical care pathways after chronic total occlusion angioplasty: A report from the OPEN-CTO (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures) stud
    Catheter Cardiovasc Interv. 2021;98:626-635.
    PubMed     Abstract available


  477. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    PubMed     Abstract available


  478. AGOSTONI P, Scott B, Budassi S, Verheye S, et al
    A prospective evaluation of a redefined version of the "minimalistic hybrid approach" algorithm for percutaneous coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2021;98:617-625.
    PubMed     Abstract available


    September 2021
  479. CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
    Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
    PubMed     Abstract available


  480. SOOMRO AY, Almaddah N, Lendel V, Agarwal SK, et al
    Elective percutaneous coronary intervention performed during contrast-induced hypotension.
    Catheter Cardiovasc Interv. 2021 Sep 22. doi: 10.1002/ccd.29958.
    PubMed     Abstract available


  481. WATANABE Y, Mitomo S, Naganuma T, Chieffo A, et al
    The importance of proximal optimization technique with intravascular imaging guided for stenting unprotected left main distal bifurcation lesions: The Milan and New-Tokyo registry.
    Catheter Cardiovasc Interv. 2021 Sep 14. doi: 10.1002/ccd.29954.
    PubMed     Abstract available


  482. ULLAH W, Zghouzi M, Ahmad B, Suleiman AM, et al
    Safety and efficacy of the polymer-free and polymer-coated drug-eluting stents in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Sep 12. doi: 10.1002/ccd.29953.
    PubMed     Abstract available


  483. SHEIBAN I, Ge Z, Kan J, Nie S, et al
    Association of peri-procedural myocardial infarction with mortality after stenting true coronary bifurcation lesions: A pooled individual participant data analysis from four randomized controlled trials.
    Catheter Cardiovasc Interv. 2021 Sep 7. doi: 10.1002/ccd.29946.
    PubMed     Abstract available


  484. BEERKENS FJ, Singh R, Cao D, Claessen BE, et al
    Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.
    Catheter Cardiovasc Interv. 2021 Sep 3. doi: 10.1002/ccd.29935.
    PubMed     Abstract available


  485. TARANTINI G, Zuccarelli V
    Percutaneous coronary intervention versus coronary artery bypass graft surgery: The battle rages on.
    Catheter Cardiovasc Interv. 2021;98:434-435.
    PubMed    


  486. MUSUMECI G, Colopi M
    Percutaneous coronary intervention outcomes in left main and multivessel disease: Navigating the patent minefield.
    Catheter Cardiovasc Interv. 2021;98:445-446.
    PubMed    


  487. OKUYA Y, Moussa ID
    Coronary bypass graft surgery accentuates proximal coronary disease progression!
    Catheter Cardiovasc Interv. 2021;98:492.
    PubMed    


  488. STABILE E, Esposito G
    Below the knee percutaneous transluminal angioplasty for claudicants: One vessel is enough to relieve symptoms.
    Catheter Cardiovasc Interv. 2021;98:570-571.
    PubMed     Abstract available


  489. POSTALIAN A, Krajcer Z
    MANTA versus Perclose for large-bore vessel closure: The evidence continues to grow.
    Catheter Cardiovasc Interv. 2021;98:586-587.
    PubMed     Abstract available


  490. COBB H, Spray B, Daily J, Dossey A, et al
    Cutting balloon angioplasty on branch pulmonary artery stenosis in pediatric patients.
    Catheter Cardiovasc Interv. 2021;98:526-532.
    PubMed     Abstract available


  491. ROCHA-SINGH KJ, Sachar R, DeRubertis BG, Nolte-Ernsting CCA, et al
    Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
    Catheter Cardiovasc Interv. 2021;98:549-558.
    PubMed     Abstract available


  492. SALAHUDDIN T, Giannopoulos S, Adams G, Armstrong EJ, et al
    Anterior, posterior, or all-vessel infrapopliteal revascularization in patients with moderate-severe claudication: Insights from the LIBERTY 360 study.
    Catheter Cardiovasc Interv. 2021;98:559-569.
    PubMed     Abstract available


  493. KATSUKI T, Yamaji K, Soga Y, Iida O, et al
    New lesion after endovascular therapy of femoropopliteal lesions for intermittent claudication.
    Catheter Cardiovasc Interv. 2021;98:E395-E402.
    PubMed     Abstract available


  494. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    PubMed     Abstract available


  495. MOCCETTI F, Wolfrum M, Bossard M, Attinger-Toller A, et al
    Reduction of MANTA-associated vascular complications after implementation of key insights on failure mechanisms.
    Catheter Cardiovasc Interv. 2021;98:E462-E465.
    PubMed     Abstract available


  496. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    PubMed     Abstract available


  497. CORDERO A, Cid-Alvarez B, Alegria E, Fernandez-Cisnal A, et al
    Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.
    Catheter Cardiovasc Interv. 2021;98:E342-E350.
    PubMed     Abstract available


  498. LHERMUSIER T, Carrie D, Cayla G, Fajadet J, et al
    Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:511-519.
    PubMed     Abstract available


  499. YAGER N, Schulman-Marcus J, Torosoff M
    Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:436-444.
    PubMed     Abstract available


  500. KERKMEIJER LSM, Chandrasekhar J, Kalkman DN, Woudstra P, et al
    Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
    Catheter Cardiovasc Interv. 2021;98:503-510.
    PubMed     Abstract available


  501. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    PubMed     Abstract available


  502. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    PubMed     Abstract available


  503. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    PubMed     Abstract available


  504. LEE JH, Kim U, Kim JS, Hong SJ, et al
    Clinical implication of neointimal burden in in-stent restenosis treated with drug-coated balloon.
    Catheter Cardiovasc Interv. 2021;98:493-502.
    PubMed     Abstract available


  505. SHAH R, Labroo A, Davis DA, Le FK, et al
    Increased risk of stent thrombosis with use of a direct oral anticoagulant and a single antiplatelet agent after PCI: A meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:E490-E492.
    PubMed    


  506. JANG WJ, Chun WJ, Park IH, Choi KH, et al
    Impact of stent designs of second-generation drug-eluting stents on long-term outcomes in coronary bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;98:458-467.
    PubMed     Abstract available


    August 2021
  507. LICHAA H
    Coronary stent positioning under live IVUS guidance in low contrast percutaneous coronary interventions: The live IVUS stenting technique.
    Catheter Cardiovasc Interv. 2021 Aug 31. doi: 10.1002/ccd.29940.
    PubMed     Abstract available


  508. YAMADA T, Washimi S, Hashimoto S, Taniguchi N, et al
    Feasibility and safety of the successive use of distal transradial access for coronary angiography and intervention in the same arm.
    Catheter Cardiovasc Interv. 2021 Aug 28. doi: 10.1002/ccd.29938.
    PubMed     Abstract available


  509. SAITO A, Dai Z, Ono M, Kanie T, et al
    The relationship between coronary stent strut thickness and the incidences of clinical outcomes after drug-eluting stent implantation: A systematic review and meta-regression analysis.
    Catheter Cardiovasc Interv. 2021 Aug 22. doi: 10.1002/ccd.29922.
    PubMed     Abstract available


  510. MATSUOKA T, Kitahara H, Saito K, Mori N, et al
    Utility of near-infrared spectroscopy to detect the extent of lipid core plaque leading to periprocedural myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29927.
    PubMed     Abstract available


  511. YIN T, Zhong X, Tao L, Hu T, et al
    Revascularization by percutaneous coronary intervention in a case of left main coronary artery atresia.
    Catheter Cardiovasc Interv. 2021 Aug 19. doi: 10.1002/ccd.29931.
    PubMed     Abstract available


  512. BASIR MB, Lemor A, Gorgis S, Taylor AM, et al
    Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29895.
    PubMed     Abstract available


  513. JIA X, Jneid H
    Practice patterns for patients with ST-elevation myocardial infarction during the early phase of the COVID-19 pandemic-Valuable lessons learned.
    Catheter Cardiovasc Interv. 2021;98:223-224.
    PubMed    


  514. GARCIA S, Stanberry L, Schmidt C, Sharkey S, et al
    Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.
    Catheter Cardiovasc Interv. 2021;98:217-222.
    PubMed     Abstract available


  515. CAO D, Dangas GD
    Assessing the risk of acute kidney injury after primary PCI: The simpler the sooner the better.
    Catheter Cardiovasc Interv. 2021;98:206-207.
    PubMed    


  516. WINSCOTT JG, Hillegass WB
    Critical limb ischemia in the end stage renal disease patient: Some next steps.
    Catheter Cardiovasc Interv. 2021;98:308-309.
    PubMed    


  517. SHROFF GR, Henry TD
    Percutaneous coronary intervention in end-stage kidney disease: Trapped between a rock and a hard place.
    Catheter Cardiovasc Interv. 2021;98:215-216.
    PubMed    


  518. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    PubMed     Abstract available


  519. DAWSON DB, Telles-Garcia NA, Atkins JL, Mina GS, et al
    End-stage renal disease patients undergoing angioplasty and bypass for critical limb ischemia have worse outcomes compared to non-ESRD patients: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:297-307.
    PubMed     Abstract available


  520. ZHAO Y, Li J, Ma S, Jiang Z, et al
    Impact of extended dual antiplatelet therapy on long-term prognosis in patients with acute coronary syndrome complicated with anemia: A sub-analysis of the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2021;98:E235-E242.
    PubMed     Abstract available


  521. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
    Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
    Catheter Cardiovasc Interv. 2021;98:E197-E204.
    PubMed     Abstract available


  522. PATHAN AZ, Aijaz S, Sheikh S, Sattar S, et al
    Randomized trial comparing radial hemostasis techniques; catechol conjugated chitosan pad (InnoSEAL) versus pneumatic compression band.
    Catheter Cardiovasc Interv. 2021;98:E181-E187.
    PubMed     Abstract available


  523. KABIR R, Vuppala S, Liu Y, Tejani I, et al
    Clinical outcomes of patients with and without chronic kidney disease undergoing endovascular revascularization of infrainguinal peripheral artery disease: Insights from the XLPAD registry.
    Catheter Cardiovasc Interv. 2021;98:310-316.
    PubMed     Abstract available


  524. HERNANDEZ-ENRIQUEZ M, Boudou N, Belle L
    Reply to "what have we learnt from the use of Papyrus covered stent in France and Spain?"
    Catheter Cardiovasc Interv. 2021;98:411-412.
    PubMed    


  525. JURADO-ROMAN A, Gonzalvez A, Jimenez-Valero S, Galeote G, et al
    What have we learnt from the use of papyrus covered stent in France and Spain?
    Catheter Cardiovasc Interv. 2021;98:410.
    PubMed    


  526. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    PubMed     Abstract available


  527. SANZ SANCHEZ J, Garbo R, Gagnor A, Oreglia J, et al
    Management and outcomes of coronary artery perforations treated with the block and deliver technique.
    Catheter Cardiovasc Interv. 2021;98:238-245.
    PubMed     Abstract available


  528. BURATTI S, Crimi G, Somaschini A, Cornara S, et al
    A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:197-205.
    PubMed     Abstract available


  529. IMAMURA T
    Implication of Impella-supported percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:E324.
    PubMed    


  530. DUNN AN, Huded C, Simpfendorfer C, Raymond R, et al
    End-stage renal disease as an independent risk factor for in-hospital mortality after coronary drug-eluting stenting: Understanding and modeling the risk.
    Catheter Cardiovasc Interv. 2021;98:246-254.
    PubMed     Abstract available


    July 2021
  531. BISWAS S, Dinh D, Duffy SJ, Brennan A, et al
    Characteristics and outcomes of unsuccessful percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29886.
    PubMed     Abstract available


  532. SCHUMACHER SP, Everaars H, Stuijfzand WJ, van Diemen PA, et al
    Viability and functional recovery after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 30. doi: 10.1002/ccd.29888.
    PubMed     Abstract available


  533. MARCUSOHN E, Zukermann R, Kerner A, Roguin A, et al
    Long-term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 14. doi: 10.1002/ccd.29870.
    PubMed     Abstract available


  534. TAVENIER AH, Claassens DMF, Hermanides RS, Vos GJA, et al
    Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y12 inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial.
    Catheter Cardiovasc Interv. 2021 Jul 7. doi: 10.1002/ccd.29861.
    PubMed     Abstract available


  535. HERMILLER JB JR, Gunnarsson CL, Ryan MP, Moore KA, et al
    The need for future coronary access following surgical or transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 6. doi: 10.1002/ccd.29841.
    PubMed     Abstract available


  536. DAI Y, Ge J
    The synergistic effect of coronary artery bifurcations and calcifications on the adverse outcomes after PCI: Is 1+1>1?
    Catheter Cardiovasc Interv. 2021;98:43-44.
    PubMed    


  537. ICHIHASHI S, Tamura Y, Maeda S, Kichikawa K, et al
    Percutaneous deep venous arterialization at femoropopliteal segment for unhealed amputated stump ulcer after below the knee amputation.
    Catheter Cardiovasc Interv. 2021;98:E124-E126.
    PubMed     Abstract available


  538. SULIMOV DS, Markuske M, Desch S, Thiele H, et al
    Management of dead space thrombosis during decannulation of peripherally inserted venoarterial extracorporeal membrane oxygenation.
    Catheter Cardiovasc Interv. 2021;98:E122-E123.
    PubMed     Abstract available


  539. AZZALINI L, Carlino M
    A new combined antegrade and retrograde approach for chronic total occlusion recanalization: Facilitated antegrade fenestration and re-entry.
    Catheter Cardiovasc Interv. 2021;98:E85-E90.
    PubMed     Abstract available


  540. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    PubMed     Abstract available


  541. WATANABE Y, Mitomo S, Naganuma T, Takagi K, et al
    Clinical impact of bifurcation angle change between diastole and systole in complex stenting for left main distal bifurcation: The Milan and New-Tokyo (MITO) Registry.
    Catheter Cardiovasc Interv. 2021;98:E24-E34.
    PubMed     Abstract available


  542. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    PubMed     Abstract available


  543. SREENIVASAN J, Abu-Haniyeh A, Hooda U, Khan MS, et al
    Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States.
    Catheter Cardiovasc Interv. 2021;98:12-21.
    PubMed     Abstract available


  544. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    PubMed     Abstract available


  545. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    PubMed     Abstract available


  546. MAILLARD L, de Labriolle A, Brasselet C, Faurie B, et al
    Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Catheter Cardiovasc Interv. 2021;98:45-54.
    PubMed     Abstract available


  547. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    PubMed     Abstract available


    June 2021
  548. OCHIUMI Y, Yamamoto M, Tsuchikane E, Muramatsu T, et al
    Predictors of prolonged guidewire manipulation time for native coronary chronic total occlusion percutaneous coronary intervention via primary antegrade approach.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29844.
    PubMed     Abstract available


  549. SCHUKRAFT S, Arroyo D, Togni M, Goy JJ, et al
    Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29837.
    PubMed     Abstract available


  550. RAHMAN F, Jneid H
    The continuing promise of the radial access for coronary interventions.
    Catheter Cardiovasc Interv. 2021;97:1397-1398.
    PubMed    


  551. NAGARAJA V, Rao SV, George S, Mamas M, et al
    Evidence-based arterial access site practice in patients with acute coronary syndromes: Has SAFARI-STEMI changed the landscape?
    Catheter Cardiovasc Interv. 2021;97:1417-1421.
    PubMed    


  552. KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
    Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
    Catheter Cardiovasc Interv. 2021;97:1399-1401.
    PubMed     Abstract available


  553. BEN-DOR I, Sharma A, Rogers T, Yerasi C, et al
    Micropuncture technique for femoral access is associated with lower vascular complications compared to standard needle.
    Catheter Cardiovasc Interv. 2021;97:1379-1385.
    PubMed     Abstract available


  554. ANDO G, Capodanno D
    Safe femoral access for STEMI patients and mortality in the new decade: Back to the future?
    Catheter Cardiovasc Interv. 2021;97:E1054-E1056.
    PubMed    


  555. OKSNES A, McEntegart M
    Intravascular lithotripsy in saphenous vein grafts and graft stent failure: A case series.
    Catheter Cardiovasc Interv. 2021;97:E945-E950.
    PubMed     Abstract available


  556. PATEL NJ, Okamoto N, Murphy J, Vengrenyuk Y, et al
    Management of calcified coronary artery bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:1407-1416.
    PubMed     Abstract available


  557. TEHRANI BN, Damluji AA, Sherwood MW, Rosner C, et al
    Transradial access in acute myocardial infarction complicated by cardiogenic shock: Stratified analysis by shock severity.
    Catheter Cardiovasc Interv. 2021;97:1354-1366.
    PubMed     Abstract available


  558. DING PYJ, Webber B, Ormiston J, Webster M, et al
    Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
    Catheter Cardiovasc Interv. 2021;97:E951-E955.
    PubMed     Abstract available


  559. AZZALINI L, Baber U, Johal GS, Farhan S, et al
    One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;97:1341-1351.
    PubMed     Abstract available


  560. KARAMASIS GV, Kalogeropoulos AS, Gamma RA, Clesham GJ, et al
    Effects of stent postdilatation during primary PCI for STEMI: Insights from coronary physiology and optical coherence tomography.
    Catheter Cardiovasc Interv. 2021;97:1309-1317.
    PubMed     Abstract available


  561. KAUL U, Abhyankar A, K Abhaichand R, Bhagwat A, et al
    Serial evaluation of vascular responses after implantation of everolimus-eluting coronary stent by optical coherence tomography.
    Catheter Cardiovasc Interv. 2021 Jun 1. doi: 10.1002/ccd.29794.
    PubMed     Abstract available


    May 2021
  562. LEE KH, Torii S, Oguri M, Miyaji T, et al
    Reduction of door-to-balloon time in patients with ST-elevation myocardial infarction by single-catheter primary percutaneous coronary intervention method.
    Catheter Cardiovasc Interv. 2021 May 31. doi: 10.1002/ccd.29797.
    PubMed     Abstract available


  563. MEDRANDA GA, Case BC, Zhang C, Rappaport H, et al
    Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29786.
    PubMed     Abstract available


  564. O'NEILL BP, Grines C, Moses JW, Ohman EM, et al
    Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29758.
    PubMed     Abstract available


  565. COSGROVE C, Hanratty CG, Hill JM, Mahadevan K, et al
    Intravascular lithotripsy for treatment of calcific coronary lesions in ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29801.
    PubMed     Abstract available


  566. ROUMELIOTIS A, Claessen BE, Sartori S, Cao D, et al
    Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2021 May 25. doi: 10.1002/ccd.29754.
    PubMed     Abstract available


  567. ELIA E, Iannaccone M, D'Ascenzo F, Gallone G, et al
    Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 May 24. doi: 10.1002/ccd.29757.
    PubMed     Abstract available


  568. BALDI C, Silverio A, Esposito L, Di Maio M, et al
    Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia.
    Catheter Cardiovasc Interv. 2021 May 5. doi: 10.1002/ccd.29738.
    PubMed     Abstract available


  569. SHOAIB A, Mohamed M, Curzen N, Ludman P, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion in prior coronary artery bypass grafting patients.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29691.
    PubMed     Abstract available


  570. TOPAZ O
    The inconsistency of manual thrombectomy and the role of contemporary thrombus grading in PCI for STEMI.
    Catheter Cardiovasc Interv. 2021;97:1149-1150.
    PubMed    


  571. SHAH J, Levy MS
    GRACEfully assessing the timeline for noninfarct-related artery intervention in ST-elevation myocardial infarction patients.
    Catheter Cardiovasc Interv. 2021;97:1160-1161.
    PubMed    


  572. SHADMAN S, Heyliger S, Watts C, Aghili N, et al
    Successful impella-assisted suction thrombectomy of right heart thrombus via the AngioVac device: Advantages, limitations, and alternatives.
    Catheter Cardiovasc Interv. 2021;97:1296-1300.
    PubMed     Abstract available


  573. ADUSUMALLI S, Dautov R
    An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
    Catheter Cardiovasc Interv. 2021;97:1213-1217.
    PubMed     Abstract available


  574. KROON HG, Tonino PAL, Savontaus M, Amoroso G, et al
    Dedicated plug based closure for large bore access -The MARVEL prospective registry.
    Catheter Cardiovasc Interv. 2021;97:1270-1278.
    PubMed     Abstract available


  575. ALLAHWALA UK, Nour D, Bhatia K, Ward MR, et al
    Prognostic impact of collaterals in patients with a coronary chronic total occlusion: A meta-analysis of over 3,000 patients.
    Catheter Cardiovasc Interv. 2021;97:E771-E777.
    PubMed     Abstract available


  576. FUKAGAWA T, Mori S, Hirano K
    Feasibility of the novel proximal superficial femoral artery puncture technique to recanalize chronic total occlusions.
    Catheter Cardiovasc Interv. 2021;97:E852-E856.
    PubMed     Abstract available


  577. KALRA S, Doshi D, Sapontis J, Kosmidou I, et al
    Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:1162-1173.
    PubMed     Abstract available


  578. ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
    An algorithmic approach to balloon-uncrossable coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:E817-E825.
    PubMed     Abstract available


  579. TESTI G, Ceccacci T, Maioli F, Grotti S, et al
    Medial-to-lateral plantar loop technique for retrograde transcollateral recanalization of the lateral plantar artery in patients with type 3 plantar arch.
    Catheter Cardiovasc Interv. 2021;97:E842-E846.
    PubMed     Abstract available


  580. ARANZULLA TC, Musumeci G
    Morphological stabilization and regression of carotid plaque following therapy with evolocumab in a high-risk patient.
    Catheter Cardiovasc Interv. 2021;97:E835-E841.
    PubMed     Abstract available


  581. WERNER GS, Yaginuma K, Koch M, Tischer K, et al
    Modulated radiation protocol achieves marked reduction of radiation exposure for chronic total coronary occlusion intervention.
    Catheter Cardiovasc Interv. 2021;97:1196-1206.
    PubMed     Abstract available


  582. CHEN S, David SW, Khan ZA, Metzger DC, et al
    One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2021;97:1120-1126.
    PubMed     Abstract available


  583. KIM MC, Bae S, Ahn Y, Sim DS, et al
    Benefit of a staged in-hospital revascularization strategy in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease: Analyses by risk stratification.
    Catheter Cardiovasc Interv. 2021;97:1151-1159.
    PubMed     Abstract available


  584. PAHUJA M, Ranka S, Chehab O, Mishra T, et al
    Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;97:1129-1138.
    PubMed     Abstract available


  585. PATTERSON C, Sapontis J, Nicholson WJ, Lombardi W, et al
    Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study.
    Catheter Cardiovasc Interv. 2021;97:1186-1193.
    PubMed     Abstract available


  586. GARCIA S, Schmidt CW, Garberich R, Henry TD, et al
    Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018.
    Catheter Cardiovasc Interv. 2021;97:1109-1117.
    PubMed     Abstract available


  587. KOLK MZH, van Veelen A, Agostoni P, van Houwelingen GK, et al
    Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion-A subanalysis of the EXPLORE trial.
    Catheter Cardiovasc Interv. 2021;97:1176-1183.
    PubMed     Abstract available


  588. MEIER D, Fournier S, Masci PG, Eeckhout E, et al
    Impact of manual thrombectomy on microvascular obstruction in STEMI patients.
    Catheter Cardiovasc Interv. 2021;97:1141-1148.
    PubMed     Abstract available


  589. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    PubMed     Abstract available


  590. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    PubMed     Abstract available


  591. LI X, Qiu M, Na K, Li Y, et al
    Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1032-1039.
    PubMed     Abstract available


  592. ZHANG J, Qiu M, Na K, Ma S, et al
    Impact of 6- versus 12-month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4-year results of the I LOVE IT 2 study.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1025-1031.
    PubMed     Abstract available


    April 2021
  593. DUNN AN, Huded C, Raymond R, Lincoff AM, et al
    Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29707.
    PubMed     Abstract available


  594. ABIZAID A, Campos CM, Guimaraes PO, Costa JR Jr, et al
    Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: Primary results of a nationwide angiographic study.
    Catheter Cardiovasc Interv. 2021 Apr 27. doi: 10.1002/ccd.29709.
    PubMed     Abstract available


  595. OBA Y, Inohara T, Takahashi M, Fukutomi M, et al
    In-hospital outcomes and usage of embolic protection devices in percutaneous coronary intervention for coronary artery bypass grafts: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2021 Apr 16. doi: 10.1002/ccd.29695.
    PubMed     Abstract available


  596. KIM M, Park KW, Lee HS, Ki YJ, et al
    The validation of the dual antiplatelet therapy score in East Asians receiving percutaneous coronary intervention with exclusively second generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29682.
    PubMed     Abstract available


  597. SHARMA SK, Fuster V, Hofstra L, Kini AS, et al
    Lessons learned from reduced acute cardiovascular events and STEMI during Covid-19.
    Catheter Cardiovasc Interv. 2021;97:850-852.
    PubMed    


  598. LOPEZ JJ, Ebinger JE, Allen S, Yildiz M, et al
    Adapting STEMI care for the COVID-19 pandemic: The case for low-risk STEMI triage and early discharge.
    Catheter Cardiovasc Interv. 2021;97:847-849.
    PubMed     Abstract available


  599. QUESADA O, Henry TD
    New generation drug eluting stents: Closing the gap in sex disparity in cardiovascular outcomes in women.
    Catheter Cardiovasc Interv. 2021;97:805-806.
    PubMed    


  600. FARHAD H, Levy MS
    PCI for left main bifurcation stenting: A treatment paradigm at a crossroads?
    Catheter Cardiovasc Interv. 2021;97:786-787.
    PubMed    


  601. NICOLAS J, Mehran R
    Bivalirudin versus heparin in PCI: Is the pendulum swinging again in favor of heparin?
    Catheter Cardiovasc Interv. 2021;97:774-775.
    PubMed    


  602. ASHLEY KE, Hillegass WB
    Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?
    Catheter Cardiovasc Interv. 2021;97:795-796.
    PubMed    


  603. FUKAGAWA T, Hirano K, Mori S, Yamawaki M, et al
    Efficacy of the novel technique HIRANODOME in preventing distal embolization during endovascular treatment of femoropopliteal lesions.
    Catheter Cardiovasc Interv. 2021;97:E697-E703.
    PubMed     Abstract available


  604. VERMA I, Chang EY, Kumar G, Sachdeva R, et al
    Catheter directed embolectomy of right atrial clot in transit-A case series.
    Catheter Cardiovasc Interv. 2021;97:869-873.
    PubMed     Abstract available


  605. CHOI CH, Hall JK, Malaver D, Applegate RJ, et al
    A novel technique for postclosure of large-bore sheaths using two Perclose devices.
    Catheter Cardiovasc Interv. 2021;97:905-909.
    PubMed     Abstract available


  606. MENDELSOHN FO, Holmes DR Jr, Hopkins LN
    Expanding the stroke team to include interventional cardiology.
    Catheter Cardiovasc Interv. 2021;97:874-875.
    PubMed     Abstract available


  607. OSMAN M, Syed M, Abdul Ghaffar Y, Patel B, et al
    Gender-based outcomes of impeller pumps percutaneous ventricular assist devices.
    Catheter Cardiovasc Interv. 2021;97:E627-E635.
    PubMed     Abstract available


  608. MODINE T, Vincent F, Delhaye C, Van Belle E, et al
    A dedicated Y-shaped percutaneous ECMO cannula for femoral 2-in-1 vascular access during high-risk procedures.
    Catheter Cardiovasc Interv. 2021;97:959-961.
    PubMed     Abstract available


  609. PROTTY MB, Hussain HI, Gallagher S, Al-Raisi S, et al
    Excimer laser coronary atherectomy during complex PCI: An analysis of 1,471 laser cases from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2021;97:E653-E660.
    PubMed     Abstract available


  610. LEE CH, Ahn JM, Kang DY, Han M, et al
    Comparison of simple versus complex stenting in patients with true distal left main bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:776-785.
    PubMed     Abstract available


  611. SHAIK A, Mosleh W, Dahal K, Pickett C, et al
    The absence of evidence is not the evidence of absence: A case report on the challenges in diagnosing ostial left main stenosis.
    Catheter Cardiovasc Interv. 2021;97:836-840.
    PubMed     Abstract available


  612. KITANI S, Igarashi Y, Tsuchikane E, Nakamura S, et al
    Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry).
    Catheter Cardiovasc Interv. 2021;97:E614-E623.
    PubMed     Abstract available


  613. FABBIOCCHI F, Calligaris G, Bartorelli AL
    Progressive growth of coronary aneurysms after bioresorbable vascular scaffold implantation: Successful treatment with OCT-guided exclusion using covered stents.
    Catheter Cardiovasc Interv. 2021;97:E676-E679.
    PubMed     Abstract available


  614. NAZIR S, Ahuja KR, Virk HUH, Elzanaty A, et al
    A meta-analysis of efficacy and safety of genotype-guided versus standard of care treatment strategies in selecting antiplatelet therapy in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;97:788-794.
    PubMed     Abstract available


  615. TARANTINI G, Masiero G, Burzotta F, Pazzanese V, et al
    Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29674.
    PubMed     Abstract available


    March 2021
  616. LIU ZY, Yin ZH, Liang CY, He J, et al
    Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29655.
    PubMed     Abstract available


  617. MOHAMED MO, Curzen N, de Belder M, Goodwin AT, et al
    Revascularisation strategies in patients with significant left main coronary disease during the COVID-19 pandemic.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29663.
    PubMed     Abstract available


  618. HU X, Qiao S, Guan C, Guo C, et al
    Angiographic characteristics and long-term outcomes of single-vessel chronic total occlusion percutaneous coronary intervention in patients with and without previous myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29651.
    PubMed     Abstract available


  619. SHAH AM, Siddiqui E, Cuenca C, Drotar P, et al
    Trends in the utilization and reimbursement of coronary revascularization in the United States Medicare population from 2010 to 2018.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29649.
    PubMed     Abstract available


  620. OTSUKA T, Ueki Y, Kavaliauskaite R, Zanchin T, et al
    Single antiplatelet therapy with use of prasugrel in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29650.
    PubMed     Abstract available


  621. WANG H, Wang HY, Yin D, Feng L, et al
    Early radial artery occlusion following the use of a transradial 7-French sheath for complex coronary interventions in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29653.
    PubMed     Abstract available


  622. PLOUMEN EH, Buiten RA, Zocca P, Doggen CJM, et al
    Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29594.
    PubMed     Abstract available


  623. GAO L, Gao Z, Song Y, Guan C, et al
    Long-term clinical outcomes in transradial versus transfemoral access for left main percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29586.
    PubMed     Abstract available


  624. WANG T, Guan H, Tian T, Guan C, et al
    Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: Data from 2,659 consecutive patients.
    Catheter Cardiovasc Interv. 2021 Mar 5. doi: 10.1002/ccd.29585.
    PubMed     Abstract available


  625. SONG L, Qiao S, Guan C, Bai Y, et al
    Association of symptom status, myocardial viability, and clinical/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 2. doi: 10.1002/ccd.29577.
    PubMed     Abstract available


  626. SMALLING RW
    Pre-transfer/PCI with ticagrelor and heparin administration in STEMI patients may be beneficial but should we do more?
    Catheter Cardiovasc Interv. 2021;97:600-601.
    PubMed    


  627. AGARWAL SK, Uretsky BF
    Is it time for a "functional" hybrid algorithm to optimize interventional results in chronic total occlusion?
    Catheter Cardiovasc Interv. 2021;97:656-657.
    PubMed    


  628. ASHLEY KE, Hillegass WB
    Antiplatelet therapy regimen and duration after percutaneous coronary intervention: Combining prediction scores with clinical judgment.
    Catheter Cardiovasc Interv. 2021;97:579-580.
    PubMed    


  629. PATEL NJ, Heuser RR
    "PROGRESS is our most important product": Adventures in CTO intervention.
    Catheter Cardiovasc Interv. 2021;97:668-669.
    PubMed    


  630. CASE BC, Satler LF
    The challenges of coronary no-reflow phenomenon.
    Catheter Cardiovasc Interv. 2021;97:612-613.
    PubMed    


  631. AREGULLIN EO, Mohammad Nijres B, Al-Khatib Y, Vettukattil J, et al
    Transcatheter Fontan completion using novel balloon and stent system.
    Catheter Cardiovasc Interv. 2021;97:679-684.
    PubMed     Abstract available


  632. N'DANDU Z, Bonilla J, Yousef GM, White CJ, et al
    Percutaneous deep vein arterialization: An emerging technique for no-option chronic limb-threatening ischemia patients.
    Catheter Cardiovasc Interv. 2021;97:685-690.
    PubMed     Abstract available


  633. MIHATOV N, Secemsky EA, Kereiakes DJ, Steg G, et al
    Utility of the dual antiplatelet therapy score to guide antiplatelet therapy: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;97:569-578.
    PubMed     Abstract available


  634. AL NASEF M, Oslizlok P, Walsh KP
    Percutaneous transcatheter occlusion of left atrioventricular valve in a patient with single ventricle and severe atrioventricular valve regurgitation.
    Catheter Cardiovasc Interv. 2021;97:E510-E513.
    PubMed     Abstract available


  635. ENOMOTO Y, Egashira Y, Iwama T
    What's happening in carotid stent? A case report of prominent plaque protrusion after carotid artery stenting observed on angioscopy.
    Catheter Cardiovasc Interv. 2021;97:E532-E535.
    PubMed     Abstract available


  636. JOSHI FR, Lonborg J, Sadjadieh G, Helqvist S, et al
    The benefit of complete revascularization after primary PCI for STEMI is attenuated by increasing age: Results from the DANAMI-3-PRIMULTI randomized study.
    Catheter Cardiovasc Interv. 2021;97:E467-E474.
    PubMed     Abstract available


  637. NAVARESE EP, Frediani L, Kandzari DE, Caiazzo G, et al
    Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study.
    Catheter Cardiovasc Interv. 2021;97:602-611.
    PubMed     Abstract available


  638. LEE SH, Choi KH, Lee JM, Shin D, et al
    Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization.
    Catheter Cardiovasc Interv. 2021;97:E454-E466.
    PubMed     Abstract available


  639. WHITBECK MG, Chambers JW
    Single-access during Impella hemodynamic support utilizing the Railway system.
    Catheter Cardiovasc Interv. 2021;97:675-678.
    PubMed     Abstract available


  640. KAYAERT P, Coeman M, Drieghe B, Bennett J, et al
    iFR uncovers profound but mostly reversible ischemia in CTOs and helps to optimize PCI results.
    Catheter Cardiovasc Interv. 2021;97:646-655.
    PubMed     Abstract available


  641. NAKAJIMA A, Araki M, Kurihara O, Minami Y, et al
    Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;97:634-645.
    PubMed     Abstract available


    February 2021
  642. TAO L, Li Z, Yin Z, Lin W, et al
    Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Feb 19. doi: 10.1002/ccd.29553.
    PubMed     Abstract available


  643. ALEJANDRO GB, Gheorghe LL, Camacho Freire S, Silva E, et al
    Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29557.
    PubMed     Abstract available


  644. REILLY JP, Parikh PB
    PCI in TAVR patients: Timing isn't everything.
    Catheter Cardiovasc Interv. 2021;97:540-541.
    PubMed    


  645. RAZZOUK L, Jneid H
    Revascularization in patients with diabetes and chronic total occlusion: The journey or the destination?
    Catheter Cardiovasc Interv. 2021;97:384-385.
    PubMed    


  646. ALQAHTANI F, Osman M, Harris AH, Hohmann SF, et al
    Mortality and functional outcomes of endovascular stroke therapy in the United States.
    Catheter Cardiovasc Interv. 2021;97:470-474.
    PubMed     Abstract available


  647. ZHANG Y, Xiang D, Lu Q, Wu M, et al
    A systematic review and meta-analysis of the performance of flow-diverting stents in the treatment of peripheral and visceral artery aneurysms.
    Catheter Cardiovasc Interv. 2021;97:461-469.
    PubMed     Abstract available


  648. KUMAR A, Sammour Y, Reginauld S, Sato K, et al
    Adverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi-center registry.
    Catheter Cardiovasc Interv. 2021;97:529-539.
    PubMed     Abstract available


  649. CHIABRANDO JG, Lombardi M, Vescovo GM, Wohlford GF, et al
    Stenting techniques for coronary bifurcation lesions: Evidence from a network meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2021;97:E306-E318.
    PubMed     Abstract available


  650. MADDER RD, VanOosterhout S, Parker J, Sconzert K, et al
    Robotic telestenting performance in transcontinental and regional pre-clinical models.
    Catheter Cardiovasc Interv. 2021;97:E327-E332.
    PubMed     Abstract available


  651. YASUMURA K, Benhuri B, Vengrenyuk Y, Petrov A, et al
    Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: A single-center, retrospective study.
    Catheter Cardiovasc Interv. 2021;97:E280-E287.
    PubMed     Abstract available


  652. OSHEROV AB, Qiang B, Butany J, Wright GA, et al
    A calcified chronic total occlusion preclinical model.
    Catheter Cardiovasc Interv. 2021;97:437-442.
    PubMed     Abstract available


  653. ABHYANKAR A, Abizaid A, Chamie D, Rathod M, et al
    Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study.
    Catheter Cardiovasc Interv. 2021;97:423-430.
    PubMed     Abstract available


  654. FLORES-UMANZOR EJ, Cepas-Guillen PL, Vazquez S, Fernandez-Valledor A, et al
    Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes.
    Catheter Cardiovasc Interv. 2021;97:376-383.
    PubMed     Abstract available


  655. SAITO Y, Cristea E, Bouras G, Abizaid A, et al
    Long-term serial functional evaluation after implantation of the Fantom sirolimus-eluting bioresorbable coronary scaffold.
    Catheter Cardiovasc Interv. 2021;97:431-436.
    PubMed     Abstract available


  656. YA'QOUB L, Gad M, Saad AM, Elgendy IY, et al
    National trends of utilization and readmission rates with intravascular ultrasound use for ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29524.
    PubMed     Abstract available


  657. ALAOUR B, Onwordi E, Khan A, Menexi C, et al
    Outcome of left main stem percutaneous coronary intervention in a UK nonsurgical center: A 5-year clinical experience.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29530.
    PubMed     Abstract available


  658. KINNAIRD T, Anderson R, Gallagher S, Sharp ASP, et al
    Vascular complications associated with intraaortic balloon pump supported percutaneous coronary intervention (PCI) and clinical outcomes from the British Cardiovascular Intervention Society National PCI Database.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29549.
    PubMed     Abstract available


  659. BRUNO F, De Filippo O, Conrotto F, D'Ascenzo F, et al
    Response to: Angiography versus FFR-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 7. doi: 10.1002/ccd.29542.
    PubMed    


  660. LEE SH, Choi J, Chang YJ, Shin ES, et al
    Sex difference in long-term clinical outcomes after percutaneous coronary intervention: A propensity-matched analysis of National Health Insurance data in Republic of Korea.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29511.
    PubMed     Abstract available


  661. CHANGAL K
    Angiography versus fractional flow rate-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 4. doi: 10.1002/ccd.29540.
    PubMed    


  662. VAN WIECHEN MP, Kroon H, Hokken TW, Ooms JF, et al
    Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29506.
    PubMed     Abstract available


  663. SHIELDS MC, Ouellette M, Kiefer N, Kohan L, et al
    Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29508.
    PubMed     Abstract available


  664. KAYANI WT, Jneid H
    Increasing stroke events in patients with ST elevation myocardial infraction and cardiogenic shock: A cause for concern.
    Catheter Cardiovasc Interv. 2021;97:226-227.
    PubMed     Abstract available


  665. AGARWAL SK, Uretsky BF
    Toward a more perfect coronary intervention....
    Catheter Cardiovasc Interv. 2021;97:245-246.
    PubMed    


  666. KERN MJ, Seto AH
    How strong is the warranty of a negative FFR? Comment on long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions by Weerts et al.
    Catheter Cardiovasc Interv. 2021;97:257-258.
    PubMed     Abstract available


  667. BUTMAN SM
    Hybrid revascularization procedures for multivessel disease: 2021.
    Catheter Cardiovasc Interv. 2021;97:265-266.
    PubMed    


  668. CELIK O, Guner A, Kalcik M, Guler A, et al
    The predictive value of CHADS2 score for subclinical cerebral ischemia after carotid artery stenting (from the PREVENT-CAS trial).
    Catheter Cardiovasc Interv. 2021;97:301-309.
    PubMed     Abstract available


  669. BARRETT C, Warsavage T, Kovach C, McGuinn E, et al
    Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program.
    Catheter Cardiovasc Interv. 2021;97:E219-E226.
    PubMed     Abstract available


  670. GALLONE G, D'Ascenzo F, Conrotto F, Costa F, et al
    Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations.
    Catheter Cardiovasc Interv. 2021;97:E227-E236.
    PubMed     Abstract available


  671. TAMARU H, Fujii K, Otsuji S, Takiuchi S, et al
    Short- and mid-term influence of drug-coated stent implantation on structural and functional vascular healing response: An optical coherence tomography and acetylcholine testing study.
    Catheter Cardiovasc Interv. 2021;97:E186-E193.
    PubMed     Abstract available


  672. WATANABE Y, Mitomo S, Naganuma T, Kawamoto H, et al
    Clinical outcomes of double stent strategy for unprotected left main distal bifurcation lesions using current generation drug eluting stent comparing to early generation drug eluting stent; The Milan and New Tokyo (MITO) registry.
    Catheter Cardiovasc Interv. 2021;97:E198-E208.
    PubMed     Abstract available


  673. HUSSAIN HI, Protty MB, Gallagher S, Al-Raisi S, et al
    The impact of coronary perforation in percutaneous interventions involving the left main stem coronary artery in the United Kingdom 2007-2014: Insights from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2021;97:E179-E185.
    PubMed     Abstract available


  674. SHARMA RK, Poulin MF, Tamez-Aguilar H, Pinto DS, et al
    Post hoc closure of large bore vascular access using the MANTA closure device.
    Catheter Cardiovasc Interv. 2021;97:282-286.
    PubMed     Abstract available


    January 2021
  675. CHIARITO M, Cao D, Nicolas J, Roumeliotis A, et al
    Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021 Jan 28. doi: 10.1002/ccd.29486.
    PubMed     Abstract available


  676. HIRAI T, Grantham JA, Sapontis J, Nicholson WJ, et al
    Development and validation of a prediction model for angiographic perforation during chronic total occlusion percutaneous coronary intervention: OPEN-CLEAN perforation score.
    Catheter Cardiovasc Interv. 2021 Jan 13. doi: 10.1002/ccd.29466.
    PubMed     Abstract available


  677. MCKENZIE A, Zhou C, Svendsen C, Anketell R, et al
    Ability of a novel shock index that incorporates invasive hemodynamics to predict mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Jan 9. doi: 10.1002/ccd.29460.
    PubMed     Abstract available


  678. TARANTINI G, Fraccaro C
    Twilight-specific light cues.
    Catheter Cardiovasc Interv. 2021;97:72-73.
    PubMed     Abstract available


  679. KRAJCER Z, Costello B
    Clinical impact of calcified nodules in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:20-21.
    PubMed     Abstract available


  680. RODRIGUEZ-PAZ E, Heuser R
    "Back to the future: Beta radiation to treat recurrent in-stent restenosis".
    Catheter Cardiovasc Interv. 2021;97:47.
    PubMed     Abstract available


  681. SMITH T, Henry TD
    Spontaneous coronary artery dissection with cardiogenic shock: How frequent is it? How should we treat it?
    Catheter Cardiovasc Interv. 2021;97:78-79.
    PubMed     Abstract available


  682. GRINES CL, Yen A
    Between a rock and a hard place: Orbital atherectomy for under-expanded stents.
    Catheter Cardiovasc Interv. 2021;97:8-9.
    PubMed     Abstract available


  683. CHUGH Y, Brilakis ES
    Intravascular lithotripsy for stent under-expansion: Panacea or Pandora's box?
    Catheter Cardiovasc Interv. 2021;97:30-31.
    PubMed     Abstract available


  684. KERN MJ
    Is stealing still a crime? Comment on left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021;97:105-107.
    PubMed     Abstract available


  685. MAESTAS CM, Blankenship JC
    Interventional economics provide a roadmap to better patient care.
    Catheter Cardiovasc Interv. 2021;97:94-96.
    PubMed     Abstract available


  686. FAN LM, Tong D, Mintz GS, Mamas MA, et al
    Breaking the deadlock of calcified coronary artery lesions: A contemporary review.
    Catheter Cardiovasc Interv. 2021;97:108-120.
    PubMed     Abstract available


  687. DI MARCO A, Anguera I, Nombela-Franco L, Oloriz T, et al
    Revascularization of coronary chronic total occlusions in an infarct-related artery and recurrence of ventricular arrhythmias among patients with secondary prevention implantable cardioverter defibrillator.
    Catheter Cardiovasc Interv. 2021;97:E1-E11.
    PubMed     Abstract available


  688. MCQUILLAN C, Jackson MWP, Brilakis ES, Egred M, et al
    Uncrossable and undilatable lesions-A practical approach to optimizing outcomes in PCI.
    Catheter Cardiovasc Interv. 2021;97:121-126.
    PubMed     Abstract available


  689. BABER U, Chandiramani R, Mehta SR, Sartori S, et al
    Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY.
    Catheter Cardiovasc Interv. 2021;97:63-71.
    PubMed     Abstract available


  690. KUME T, Murasato Y, Yamada R, Koyama T, et al
    Effect of proximal balloon edge dilation technique for opening a side branch ostium in repetitive-proximal optimizing technique sequence.
    Catheter Cardiovasc Interv. 2021;97:E12-E18.
    PubMed     Abstract available


  691. CHEN K, Scridon T, Chait R
    Inadvertent aortocoronary arteriovenous fistula after CABG: Systematic review of case reports.
    Catheter Cardiovasc Interv. 2021;97:E19-E25.
    PubMed     Abstract available


  692. AZZALINI L, Alaswad K, Uretsky BF, Agostoni P, et al
    Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2021;97:E40-E50.
    PubMed     Abstract available


  693. LAMELAS P, Padilla L, Abud M, Cigalini I, et al
    In-stent chronic total occlusion angioplasty in the LATAM-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:E34-E39.
    PubMed     Abstract available


  694. MOROFUJI T, Kuramitsu S, Shinozaki T, Jinnouchi H, et al
    Clinical impact of calcified nodule in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:10-19.
    PubMed     Abstract available


  695. WIEBE J, Hofmann FJ, Dorr O, Bauer T, et al
    Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation.
    Catheter Cardiovasc Interv. 2021;97:56-62.
    PubMed     Abstract available


  696. NEUPANE S, Basir M, Tan C, Sultan A, et al
    Feasibility and safety of orbital atherectomy for the treatment of in-stent restenosis secondary to stent under-expansion.
    Catheter Cardiovasc Interv. 2021;97:2-7.
    PubMed     Abstract available


    December 2020
  697. SCOTTI A, Godino C, Munafo A, Pivato CA, et al
    Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29425.
    PubMed     Abstract available


  698. BLOOM JE, Dinh DT, Noaman S, Martin C, et al
    Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Dec 16. doi: 10.1002/ccd.29436.
    PubMed     Abstract available


  699. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    PubMed     Abstract available


  700. TOKUDA T, Mori S, Oba Y, Koshida R, et al
    Comparison of ultrasound-guided versus angiography-guided endovascular treatment for femoropopliteal artery occlusive disease.
    Catheter Cardiovasc Interv. 2020 Dec 12. doi: 10.1002/ccd.29437.
    PubMed     Abstract available


  701. ASIF A, Sezer A, Thoma F, Toma C, et al
    Relationship between predicting bleeding complication in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score and mortality among patients with atrial fibrillation undergoing percutaneous coronary interv
    Catheter Cardiovasc Interv. 2020 Dec 9. doi: 10.1002/ccd.29399.
    PubMed     Abstract available


  702. COCKBURN J, Kemp T, Ludman P, Kinnaird T, et al
    Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly.
    Catheter Cardiovasc Interv. 2020 Dec 6. doi: 10.1002/ccd.29406.
    PubMed     Abstract available


  703. ABIZAID A, Kedev S, Ali RBM, Santoso T, et al
    Imaging and 2-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold: The MeRes-1 extend trial.
    Catheter Cardiovasc Interv. 2020 Dec 2. doi: 10.1002/ccd.29396.
    PubMed     Abstract available


  704. LAZKANI M, Tripathi B, Dattilo P
    Impact of intracoronary imaging on in-hospital mortality and 30-day readmission rates following percutaneous coronary intervention: A nationwide readmissions database analysis.
    Catheter Cardiovasc Interv. 2020 Dec 2. doi: 10.1002/ccd.29394.
    PubMed     Abstract available


    November 2020
  705. GIFFT K, Omran J, Ghrair F, Allaham H, et al
    Impact of preexisting coronary arterial disease in patients undergoing percutaneous mitral valve repair (MitraClip).
    Catheter Cardiovasc Interv. 2020 Nov 28. doi: 10.1002/ccd.29404.
    PubMed     Abstract available


  706. LABIN JE, Saggar R, Yang EH, Lluri G, et al
    Left main coronary artery compression in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
    PubMed     Abstract available


  707. BLUM M, Cao D, Chandiramani R, Goel R, et al
    Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29402.
    PubMed     Abstract available


  708. AHSAN MJ, Lateef N, Latif A, Malik SU, et al
    A systematic review and meta-analysis of impact of baseline thrombocytopenia on cardiovascular outcomes and mortality in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 24. doi: 10.1002/ccd.29405.
    PubMed     Abstract available


  709. PROTTY MB, Gallagher S, Farooq V, Sharp AS, et al
    Combined use of rotational and excimer lASER coronary atherectomy (RASER) during complex coronary angioplasty-An analysis of cases (2006-2016) from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2020 Nov 17. doi: 10.1002/ccd.29377.
    PubMed     Abstract available


  710. KAWASHIMA H, Hara H, Wang R, Ono M, et al
    Usefulness of updated logistic clinical SYNTAX score based on MI-SYNTAX score in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29383.
    PubMed     Abstract available


  711. TARANTINI G, Fraccaro C
    Aortic valve replacement plus revascularization: The battle of surgical versus transcatheter approach still rages.
    Catheter Cardiovasc Interv. 2020;96:1126-1127.
    PubMed     Abstract available


  712. POSTALIAN A, Krajcer Z
    Chronic total occlusion percutaneous coronary intervention: The Latin American experience.
    Catheter Cardiovasc Interv. 2020;96:1056-1057.
    PubMed    


    October 2020
  713. GARG A, Rout A, Raheja H, Hakeem H, et al
    Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Oct 26. doi: 10.1002/ccd.29338.
    PubMed     Abstract available


  714. SOGA Y, Takahara M, Ito N, Katsuki T, et al
    Clinical impact of intravascular ultrasound-guided balloon angioplasty in patients with chronic limb threatening ischemia for isolated infrapopliteal lesion.
    Catheter Cardiovasc Interv. 2020 Oct 21. doi: 10.1002/ccd.29347.
    PubMed     Abstract available


  715. YAMAMOTO K, Shiomi H, Morimoto T, Takeji Y, et al
    Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Catheter Cardiovasc Interv. 2020 Oct 16. doi: 10.1002/ccd.29335.
    PubMed     Abstract available


  716. SEPULVEDA P, Hameau R, Backhouse C, Charme G, et al
    Mid-term follow-up of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: An experience in Latin America.
    Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29322.
    PubMed     Abstract available


  717. GOEL R, Cao D, Chandiramani R, Roumeliotis A, et al
    Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.
    Catheter Cardiovasc Interv. 2020 Oct 10. doi: 10.1002/ccd.29314.
    PubMed     Abstract available


  718. MASDJEDI K, van Zandvoort LJ, Balbi MM, Nuis RJ, et al
    Validation of novel 3-dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting.
    Catheter Cardiovasc Interv. 2020 Oct 6. doi: 10.1002/ccd.29311.
    PubMed     Abstract available


  719. PAJJURU VS, Thandra A, Guddeti RR, Kothapalli SR, et al
    ST-elevation myocardial infarction in nonagenarians: A nationwide analysis of trends and outcomes in the United States.
    Catheter Cardiovasc Interv. 2020 Oct 3. doi: 10.1002/ccd.29313.
    PubMed     Abstract available


    September 2020
  720. LUNARDI M, Franzese I, Faggian G, Ribichini FL, et al
    Hybrid treatment of aortic aneurism, type-A dissection, and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Sep 26. doi: 10.1002/ccd.29303.
    PubMed     Abstract available


  721. KUNO T, Takagi H, Ando T, Kodaira M, et al
    Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2020 Sep 7. doi: 10.1002/ccd.29236.
    PubMed     Abstract available


  722. LOPERA JE, Jen S
    Superior vena cava filter placement over existing central venous lines: Is line removal necessary?
    Catheter Cardiovasc Interv. 2020;96:651-656.
    PubMed     Abstract available


  723. TANNOUS P, Popescu A, Forbess L, Nugent A, et al
    Transcatheter biventricular conversion in an adult patient with a 1.5 ventricle Glenn palliation and superior vena cava syndrome.
    Catheter Cardiovasc Interv. 2020;96:633-637.
    PubMed     Abstract available


  724. MATHIS C, Romans R, Divekar A
    Variation in the outer diameter of vascular sheaths commonly used in infant cardiac catheterization.
    Catheter Cardiovasc Interv. 2020;96:620-625.
    PubMed     Abstract available


  725. ZILBERSZAC R, Chandiramani R, Hengstenberg C, Sartori S, et al
    Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2020;96:E377-E386.
    PubMed     Abstract available


  726. ARANZULLA TC
    One, two, three ... breakdance and twist.
    Catheter Cardiovasc Interv. 2020;96:601-608.
    PubMed     Abstract available


  727. TOVAR FORERO MN, Van Mieghem NM, Daemen J
    Stent underexpansion due to heavy coronary calcification resistant to rotational atherectomy: A case for coronary lithoplasty?
    Catheter Cardiovasc Interv. 2020;96:598-600.
    PubMed     Abstract available


  728. ABU SHARAR H, Helfert S, Vafaie M, Pleger ST, et al
    Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Catheter Cardiovasc Interv. 2020;96:578-585.
    PubMed     Abstract available


  729. KANDZARI DE, Lembo NJ, Carlson HD, Kalynych A, et al
    Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study.
    Catheter Cardiovasc Interv. 2020;96:567-576.
    PubMed     Abstract available


  730. PARR CJ, Sharma R, Arora RC, Singal R, et al
    Outcomes of extracorporeal membrane oxygenation support in the cardiac catheterization laboratory.
    Catheter Cardiovasc Interv. 2020;96:547-555.
    PubMed     Abstract available


  731. DE ROECK F, Tijskens M, Segers VFM
    Coronary-subclavian steal syndrome, an easily overlooked entity in interventional cardiology.
    Catheter Cardiovasc Interv. 2020;96:614-619.
    PubMed     Abstract available


  732. PROMPHAN W, Han Siang K, Prachasilchai P, Jarutach J, et al
    Feasibility and early outcomes of aortic coarctation treatments with BeGraft Aortic stent.
    Catheter Cardiovasc Interv. 2020;96:E310-E316.
    PubMed     Abstract available


  733. NOAMAN S, Andrianopoulos N, Brennan AL, Dinh D, et al
    Outcomes of cardiogenic shock complicating acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020;96:E257-E267.
    PubMed     Abstract available


  734. GALLONE G, D'Ascenzo F, Boccuzzi G, Cortese B, et al
    Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stent.
    Catheter Cardiovasc Interv. 2020;96:E248-E256.
    PubMed     Abstract available


  735. KOREN O, Abu Rajab Saaida R, Rozner E, Turgeman Y, et al
    Outcomes and safety of concurrent coronary and peripheral catheterization (REVascularization in concomitant PERIpheral artery disease and coronary artery disease REV-PERICAD Study).
    Catheter Cardiovasc Interv. 2020;96:E317-E323.
    PubMed     Abstract available


  736. SONCK J, Collet C, Mizukami T, Vandeloo B, et al
    Motorized fractional flow reserve pullback: Accuracy and reproducibility.
    Catheter Cardiovasc Interv. 2020;96:E230-E237.
    PubMed     Abstract available


  737. HASEGAWA K, Yamamoto W, Nakabayashi S, Otsuji S, et al
    Streamlined reverse wire technique for the treatment of complex bifurcated lesions.
    Catheter Cardiovasc Interv. 2020;96:E287-E291.
    PubMed     Abstract available


  738. RADHOE SP, Schuurman AS, Ligthart JM, Witberg K, et al
    Two decades after coronary radiation therapy: A single center longitudinal clinical study.
    Catheter Cardiovasc Interv. 2020;96:E204-E212.
    PubMed     Abstract available


  739. FEMIA G, Faour A, Assad J, Sharma L, et al
    Comparing the clinical and prognostic impact of proximal versus nonproximal lesions in dominant right coronary artery ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Sep 1. doi: 10.1002/ccd.29245.
    PubMed     Abstract available


    August 2020
  740. D'ENTREMONT MA, Laferriere C, Berube S, Couture EL, et al
    The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention.
    Catheter Cardiovasc Interv. 2020 Aug 29. doi: 10.1002/ccd.29144.
    PubMed     Abstract available


  741. FEGHALY J, Muskula P, Kumar S, Helmy T, et al
    Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29218.
    PubMed     Abstract available


  742. BOM MJ, Schumacher SP, Driessen RS, van Diemen PA, et al
    Non-invasive procedural planning using computed tomography-derived fractional flow reserve.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29210.
    PubMed     Abstract available


  743. NAIDU SS, Coylewright M, Hawkins BM, Meraj P, et al
    Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions 2020 think tank.
    Catheter Cardiovasc Interv. 2020 Aug 25. doi: 10.1002/ccd.29197.
    PubMed     Abstract available


  744. SHAH H, Patel S, Solanki S, Wudexi I, et al
    Clinical characteristics and in hospital outcomes of heart transplant recipients undergoing percutaneous coronary intervention: Insights from the National Inpatient Sample.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29184.
    PubMed     Abstract available


  745. SAGLIETTO A, D'Ascenzo F, Errigo D, Leonardi S, et al
    Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29192.
    PubMed     Abstract available


  746. LAFONT A, Sinnaeve PR, Cuisset T, Cook S, et al
    Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Aug 6. doi: 10.1002/ccd.29159.
    PubMed     Abstract available


  747. GEORGE JC, Tabaza L, Janzer S
    Robotic-assisted balloon angioplasty and stent placement with distal embolic protection device for severe carotid artery stenosis in a high-risk surgical patient.
    Catheter Cardiovasc Interv. 2020;96:410-412.
    PubMed     Abstract available


  748. QIU Z, Liu J, Huang R, Liu D, et al
    Incidence, risk, and treatment of binary restenosis after vertebral artery stenting.
    Catheter Cardiovasc Interv. 2020;96:404-409.
    PubMed     Abstract available


  749. YAN C, Wan L, Li L, Li H, et al
    Transfemoral transcatheter puncture of interventricular septum in a swine model: A novel transfemoral-venous access to left ventricle with the assistance of arterio-venous circuit.
    Catheter Cardiovasc Interv. 2020;96:488-496.
    PubMed     Abstract available


  750. BUNCH F, Nair P, Aggarwala G, Dippel E, et al
    A universal drug delivery catheter for the treatment of infrapopliteal arterial disease using liquid therapy.
    Catheter Cardiovasc Interv. 2020;96:393-401.
    PubMed     Abstract available


  751. SIVAKUMAR K, Anantharaj A, Raghuram P, Krishna Kumar R, et al
    First in man study of a new semi-open cell design Zephyr cobalt-chromium stent in large vessels and conduits.
    Catheter Cardiovasc Interv. 2020;96:367-375.
    PubMed     Abstract available


  752. BARBASH IM, Kornowski R, Berkovitch A, Assali A, et al
    Percutaneous nitinol-based vascular closure device for large bore arterial access hemostasis: Results of a prospective multicenter study.
    Catheter Cardiovasc Interv. 2020;96:473-478.
    PubMed     Abstract available


  753. GUREVICH S, Prins KW
    The evolving role of interventional cardiology in the treatment of pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Aug 1. doi: 10.1002/ccd.29146.
    PubMed     Abstract available


    July 2020
  754. SHAH H, Ramineni G, Varghese R, Thwe EE, et al
    Outcomes of percutaneous coronary interventions in patients with liver transplant.
    Catheter Cardiovasc Interv. 2020 Jul 29. doi: 10.1002/ccd.29168.
    PubMed     Abstract available


  755. KOTRONIAS RA, Bray JH, Scarsini R, Rajasundaram S, et al
    Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic re
    Catheter Cardiovasc Interv. 2020 Jul 14. doi: 10.1002/ccd.29110.
    PubMed     Abstract available


  756. CHIEW KLX, Lim PO
    Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29099.
    PubMed     Abstract available


    June 2020
  757. NIKOLAKOPOULOS I, Choi JW, Alaswad K, Khatri JJ, et al
    Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2020 Jun 29. doi: 10.1002/ccd.29106.
    PubMed     Abstract available


  758. YOUNG L, Kapadia S, Khatri J
    Optimizing complex, high-risk indicated percutaneous coronary interventions: The future of interventional cardiology.
    Catheter Cardiovasc Interv. 2020 Jun 27. doi: 10.1002/ccd.29127.
    PubMed    


  759. KAPUR NK, Hirst CS, Davila CD, Garcia R, et al
    Single stick access using a VA-ECMO arterial return cannula for coronary intervention in cardiogenic shock.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29073.
    PubMed     Abstract available


  760. SAITO S, Ikeda N, Toi S, Nakamura M, et al
    Gadolinium contrast balloon pulmonary angioplasty for a patient with chronic thromboembolic pulmonary hypertension and severe iodine allergy.
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.29004.
    PubMed     Abstract available


  761. CONROTTO F, D'Ascenzo F, Piroli F, Franze A, et al
    Percutaneous coronary intervention of unprotected left main and bifurcation in octogenarians: Subanalysis from RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life).
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.29048.
    PubMed     Abstract available


    May 2020
  762. SEIF S, Ayuna A, Kumar A, Macdonald J, et al
    Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 May 30. doi: 10.1002/ccd.29050.
    PubMed     Abstract available


  763. ELEID MF, Zheng PP, Gulati R, Bergman P, et al
    Remote robotic percutaneous coronary intervention: An animal feasibility study.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28978.
    PubMed     Abstract available


  764. SAMMOUR Y, Kadri AN, Gajulapalli RD, Kaur M, et al
    Comparison of acute recoil after valve deployment and after post-dilation in patients undergoing transfemoral-transcatheter aortic valve replacement with SAPIEN-3 valve.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28968.
    PubMed     Abstract available


  765. EFFOE VS, Kumar G, Sachdeva R
    Intravascular ultrasound-guided pulmonary artery embolectomy for saddle pulmonary embolism.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28985.
    PubMed     Abstract available


  766. RILEY RF, Henry TD, Mahmud E, Kirtane AJ, et al
    SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28994.
    PubMed    


  767. BOX LC, Blankenship JC, Henry TD, Messenger JC, et al
    SCAI Position Statement on the Performance of Percutaneous Coronary Intervention in Ambulatory Surgical Centers.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28991.
    PubMed     Abstract available


  768. HIGUCHI S, Kabeya Y, Nishina Y, Miura Y, et al
    Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28958.
    PubMed     Abstract available


  769. FERLINI M, Musumeci G, Grieco N, Trabattoni D, et al
    Follow-up strategies and individual risk profile after percutaneous coronary intervention: The prospective post percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28964.
    PubMed     Abstract available


  770. BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
    Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
    Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
    PubMed     Abstract available


    April 2020
  771. AZZALINI L, Johal GS, Baber U, Bander J, et al
    Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Apr 25. doi: 10.1002/ccd.28931.
    PubMed     Abstract available


  772. HARA H, Kogame N, Takahashi K, Modolo R, et al
    Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28898.
    PubMed     Abstract available


  773. THOMSON VS, Varghese MJ, Chacko ST, Varghese L, et al
    Coronary artery disease management and cost implications with fractional flow reserve guided coronary intervention in Indian patients with stable ischemic coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28897.
    PubMed     Abstract available


  774. YAP J, Chen S, Smith TWR, Rogers JH, et al
    Transjugular mitral valve repair with the MitraClip: A step-by-step guide.
    Catheter Cardiovasc Interv. 2020 Apr 7. doi: 10.1002/ccd.28902.
    PubMed     Abstract available


    March 2020
  775. YOUNG L, Harb SC, Puri R, Khatri J, et al
    Percutaneous coronary intervention of an anomalous coronary chronic total occlusion: The added value of three-dimensional printing.
    Catheter Cardiovasc Interv. 2020 Mar 31. doi: 10.1002/ccd.28625.
    PubMed     Abstract available


  776. GIANNINI F, Pagnesi M, Campo G, Donahue M, et al
    Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational study.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28798.
    PubMed     Abstract available


  777. CHANDRASEKHAR J, Kerkmeijer LS, Kalkman DN, Sartori S, et al
    Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28853.
    PubMed     Abstract available


  778. BRENER SJ, Lembo NJ, Kandzari DE, Sabate M, et al
    Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial.
    Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28858.
    PubMed     Abstract available


  779. LEISTNER DM, Dietrich S, Erbay A, Steiner J, et al
    Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28839.
    PubMed     Abstract available


  780. BAWAMIA BR, Egred M, Jackson M, Purcell I, et al
    Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
    Catheter Cardiovasc Interv. 2020 Mar 5. doi: 10.1002/ccd.28818.
    PubMed     Abstract available


  781. PRASAD A, Rosenthal NA, Kartashov A, Knish K, et al
    Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28824.
    PubMed     Abstract available


    February 2020
  782. KWOK CS, Chatterjee S, Bagur R, Sharma K, et al
    Multiple unplanned readmissions after discharge for an admission with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 28. doi: 10.1002/ccd.28797.
    PubMed     Abstract available


  783. KHEIRI B, Rao SV, Osman M, Simpson TF, et al
    Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.
    Catheter Cardiovasc Interv. 2020 Feb 24. doi: 10.1002/ccd.28800.
    PubMed     Abstract available


  784. AOI S, Baber U, Kovacic JC, Mehran R, et al
    Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28784.
    PubMed     Abstract available


  785. NOAMAN S, O'Brien J, Andrianopoulos N, Brennan AL, et al
    Clinical outcomes following ST-elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28802.
    PubMed     Abstract available


  786. SHAH SR, Kiemeneij F, Khuddus MA
    Distal arteriovenous fistula formation after percutaneous coronary intervention: An old complication of a new access site.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28772.
    PubMed     Abstract available


  787. VEROUHIS D, Sorensson P, Gourine A, Henareh L, et al
    Long-term effect of remote ischemic conditioning on infarct size and clinical outcomes in patients with anterior ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28760.
    PubMed     Abstract available


    January 2020
  788. QUADROS A, Belli KC, de Paula JET, de Magalhaes Campos CAH, et al
    Chronic total occlusion percutaneous coronary intervention in Latin America.
    Catheter Cardiovasc Interv. 2020 Jan 28. doi: 10.1002/ccd.28744.
    PubMed     Abstract available


  789. BUGANI G, Ponticelli F, Giannini F, Gallo F, et al
    Practical guide to prevention of contrast-induced acute kidney injury after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 22. doi: 10.1002/ccd.28740.
    PubMed     Abstract available


  790. ALAWAMI M, Thirunavukarasu S, Ahmed J, El-Omar M, et al
    Intravascular lithotripsy to treat an underexpanded coronary stent: 4-Month angiographic and OCT follow-up.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28738.
    PubMed     Abstract available


  791. XU MX, Ruddy TD, Schoenhagen P, Bartel T, et al
    The CatLet score and outcome prediction in acute myocardial infarction for patients undergoing primary percutaneous intervention: A proof-of-concept study.
    Catheter Cardiovasc Interv. 2020 Jan 14. doi: 10.1002/ccd.28724.
    PubMed     Abstract available


  792. BURZOTTA F, Aurigemma C, Romagnoli E, Shoeib O, et al
    A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 11. doi: 10.1002/ccd.28697.
    PubMed     Abstract available


  793. ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
    Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
    PubMed     Abstract available


  794. NAI FOVINO L, Scotti A, Massussi M, Fabris T, et al
    Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28720.
    PubMed     Abstract available


  795. PRANATA R, Tondas AE, Vania R, Toruan MPL, et al
    Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: Systematic review and meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28709.
    PubMed     Abstract available


  796. COSTANTINI CR, Denk MA, De Macedo RM, Tarbine SG, et al
    Absorb bioresorbable vascular scaffold outcomes following implantation with routine intravascular imaging guidance.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28699.
    PubMed     Abstract available


    December 2019
  797. GARCIA-GARCIA HM, Adamo M, Soud M, Yacob O, et al
    Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX)
    Catheter Cardiovasc Interv. 2019 Dec 28. doi: 10.1002/ccd.28661.
    PubMed     Abstract available


  798. KWOK CS, Amin AP, Shah B, Kinnaird T, et al
    Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28660.
    PubMed     Abstract available


  799. YBARRA LF, Dandona S, Daneault B, Rinfret S, et al
    Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28663.
    PubMed     Abstract available


  800. YAP J, Teo TY, Foong P, Binte Hussin N, et al
    A randomized controlled trial on the effectiveness of a portable patient education video prior to coronary angiography and angioplasty.
    Catheter Cardiovasc Interv. 2019 Dec 22. doi: 10.1002/ccd.28655.
    PubMed     Abstract available


  801. NAGARAJA V, Schwarz K, Moss S, Kwok CS, et al
    Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data.
    Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28646.
    PubMed     Abstract available


  802. HONDA Y, Araki M, Yamawaki M, Hirano K, et al
    The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610.
    PubMed     Abstract available


  803. XENOGIANNIS I, Choi JW, Alaswad K, Khatri JJ, et al
    Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28614.
    PubMed     Abstract available


  804. HODSON RW, Jin R, Ring ME, Gafoor S, et al
    Intrathoracic complications associated with trans-femoral transcatheter aortic valve replacement: Implications for emergency surgical preparedness.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28620.
    PubMed     Abstract available


    November 2019
  805. MANGELS D, Penny W, Reeves R
    Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
    PubMed     Abstract available


  806. AMR BS, Lippmann M, Tobbia P, Isom N, et al
    Impact of short term oral steroid use for intravenous contrast media hypersensitivity prophylaxis in diabetic patients undergoing nonemergent coronary angiography or interventions.
    Catheter Cardiovasc Interv. 2019 Nov 26. doi: 10.1002/ccd.28618.
    PubMed     Abstract available


  807. ALSANJARI O, Chouari T, Williams T, Myat A, et al
    Angiographically visible coronary artery collateral circulation improves prognosis in patients presenting with acute ST segment-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28532.
    PubMed     Abstract available


  808. BAZARBASHI N, Ahuja K, Gad MM, Sammour YM, et al
    The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28585.
    PubMed     Abstract available


  809. ALQAHTANI F, Balla S, AlHajji M, Chaudhary F, et al
    Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28593.
    PubMed     Abstract available


  810. RUSSO JJ, Prasad M, Doshi D, Karmpaliotis D, et al
    Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28557.
    PubMed     Abstract available


    October 2019
  811. HANNAN EL, Zhong Y, Ling FSK, Tamis-Holland J, et al
    Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs.
    Catheter Cardiovasc Interv. 2019 Oct 23. doi: 10.1002/ccd.28526.
    PubMed     Abstract available


  812. ALRAIES MC, Kaki A, Kajy M, Blank N, et al
    Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28509.
    PubMed     Abstract available


  813. RAJKUMAR CA, Cook C, Shalhoub J, Chukwuemeka A, et al
    Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28558.
    PubMed     Abstract available


  814. CANTOR WJ, Lavi S, Dzavik V, Cairns J, et al
    Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28540.
    PubMed     Abstract available


    September 2019
  815. PLITT A, Claessen BE, Sartori S, Baber U, et al
    Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2019 Sep 6. doi: 10.1002/ccd.28488.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vascular Surgery is free of charge.